Ophthalmology

Ophthalmology is the specialty of very small operations with very large consequences. Removing a cataract takes about as long as a coffee break, and in an eye whose retina and optic nerve are healthy it can return the detail needed to recognise a face across a room. A laser treatment lasting seconds can stop a retinal tear becoming a detachment. The size of eye surgery and the size of what rests on it have almost nothing to do with each other.

What follows explains what each condition is, what the scans can and cannot see, what the operations involve, and where the honest answer is that nothing needs doing yet. An eye department that never tells anyone no is not being careful.

What this unit covers

Ophthalmology looks like one specialty from the outside and behaves like six from the inside. The lens, the cornea, the retina, the optic nerve, the muscles that aim the eyes and the lids that protect them fail in different ways, on different timescales, and are repaired by surgeons who have spent their careers on one of them. A cataract surgeon and a retinal surgeon work through incisions of much the same size and share almost nothing else about their day. The department is organised around that reality, and the work divides into eight lanes, of which most people only ever need one.

• Cataract — what a clouding lens does to sight, and when treating it is worth it, the operation itself, the artificial lens that replaces the natural one, the recovery week by week, and the late clouding that appears behind a good implant.
• Laser and lens-based vision correction — what laser vision correction does to the cornea, the differences between LASIK, PRK and SMILE, implantable lenses for eyes laser cannot safely treat, refractive lens exchange for the over-forty-fives, who these operations suit and who they do not, and the risks.
• Glaucoma — the disease that removes sight without announcing itself, what an eye pressure reading does and does not mean, how it is treated, and the laser and surgical options for eyes drops cannot hold.
• Retina — macular degeneration, injections given into the eye, diabetic eye disease, retinal detachment, vitrectomy, and floaters and flashes.
• Cornea and ocular surface — keratoconus, corneal cross-linking, corneal transplant, dry eye, and pterygium.
• Children’s eyes and eye alignment — children’s vision, including the window during which a lazy eye can still be corrected, and strabismus surgery, performed on adults as well as children.
• Functional eyelid and tear drainage — the lid problems that damage sight or the surface of the eye: a lid heavy enough to cut into the visual field, a lid rolling inwards or outwards, a tear duct that has stopped draining.
• Diagnostics — the scans and measurements that decide everything else, and what each cannot show.

Three further sections are practical rather than clinical: the subspecialties that make up the team, what can be done in one visit and what needs a second, and the ordinary mechanics of an eye appointment.

Some eye-adjacent work sits outside this unit on purpose. Cosmetic eyelid surgery — reshaping lids that work perfectly well, for appearance — belongs to the plastic surgery team; this unit holds the functional half of the eyelid only. The blood sugar control that determines whether diabetic eye disease progresses belongs to endocrinology: the unit screens the retina and treats what it finds, and cannot substitute for the medical management that decides the trajectory. Multiple sclerosis is diagnosed and treated by a neurology team; where an eye finding is what brings someone in, ophthalmology’s part is to identify it and pass it on.

There is also a difference between an eye department and an eye practice, and it matters only on the rare days when something is not straightforward. A surgeon working alone can examine an eye and operate on it. Ophthalmology at Acıbadem International is organised as a hospital department rather than as a single-surgeon practice, so the subspecialties set out in this unit’s scope sit alongside each other rather than being referred out.

Finally, the things this unit does not do. It does not remove a cataract that is not interfering with the way somebody lives, on the grounds that it is there. It does not promise anybody freedom from glasses, with any lens, at any price. It does not put a multifocal lens into an eye with significant macular disease or advanced optic nerve damage, because the lens takes contrast from an eye that has none to spare. It does not laser a prescription that is still moving, or a cornea too thin or too irregular to lose tissue safely. Each refusal costs an operation and prevents a bad outcome, which is the trade the department is set up to make.

Cataract surgery

Cataract surgery removes the eye’s own lens once it has become cloudy and replaces it with a clear artificial one. That single sentence covers the whole operation; everything else — the machines, the incision size, the choice of implant — is detail about how the cloudy lens comes out and how well the replacement is aimed. It is among the most frequently performed operations in medicine, and it is done on people who are awake, in a day-surgery unit, through a cut of about two to three millimetres that usually needs no stitch.

Two things surprise people most. The first is how short it is: commonly around fifteen minutes of operating inside a hospital visit of a few hours. The second is that the eye is numb but not asleep. Vision does not switch off, and most people describe watching lights and colours move throughout — unlike anything else, and, once expected, not distressing.

What cataract surgery removes, and what stays behind

The natural lens sits behind the pupil inside a transparent envelope called the capsular bag, roughly the shape and thickness of an aspirin. In a cataract, the lens material inside that bag has gone yellow, cloudy or hard. Surgery removes the material and leaves the bag, and the implant goes into that same bag, in the position the natural lens occupied, held by two flexible arms that spring open against the envelope.

That distinction explains much of what follows. Because the bag remains, the implant sits where the eye expects a lens to be, which is why the optics work so well — and because the bag remains, its back wall can slowly cloud months or years later, a completely different problem from the original cataract, dealt with under secondary cataract and YAG laser. The implant itself is permanent: intraocular lenses do not wear out, need no replacing on a schedule, and are invisible to anybody looking at the eye. They can be exchanged if something is genuinely wrong, but an exchange is a second operation inside the eye and is not undertaken for mild dissatisfaction.

The measurements that come before the operating theatre

The part of cataract surgery that most determines the result happens beforehand, at a machine rather than a microscope. Biometry measures the length of the eye, the curvature of the cornea, the depth of the front chamber and the thickness of the natural lens, and feeds those numbers into formulas that calculate the implant power needed to land the eye on its target focus. It is a scan rather than a test: the eye rests against a chin support for a few minutes, and in most modern systems nothing touches it.

Three ordinary things distort those measurements, and all three are checked for. A dry, irregular ocular surface changes corneal readings enough to shift the implant power, which is why dry eye is treated before the eye is measured rather than after. Contact lenses reshape the cornea and have to be left out beforehand, rigid lenses for considerably longer than soft ones. And an eye that has had laser vision correction has a cornea the standard formulas were never designed for, so a different calculation is used and the prediction is honestly less precise — a point that matters to anyone who had LASIK in their thirties and reaches cataract age in their sixties.

The examination alongside the scan looks for what will limit the result whatever the surgery achieves: the macula, the optic nerve, the inner cell layer of the cornea, and whether the pupil dilates. An eye with a cataract and a scarred macula will see better afterwards but not well, and saying so beforehand is the difference between a satisfied patient and a disappointed one.

Anaesthesia for cataract surgery (anesthesia for cataract surgery)

Almost all adult cataract surgery is done under local anesthesia, and in most eyes that means anaesthetic drops alone. The drops numb the surface completely, and a small amount of anaesthetic can also be placed inside the front of the eye during the operation. Nobody is put to sleep for a routine cataract. General anaesthesia is kept for the situations that genuinely need it: young children, adults who cannot lie still or flat, severe tremor, unmanageable claustrophobia, and some complex second operations.

Where drops are not enough — a very anxious patient, a dense cataract expected to take longer, an eye that will not stay still — an injection of anaesthetic can be placed around the eye instead. That numbs the muscles as well as the surface, so the eye stops moving and vision usually greys out for an hour or two, which is expected and temporary.

Sedation is a separate decision from anesthesia: a light sedative through a cannula takes the edge off without switching consciousness off, and many people have it. What no local anesthesia does is remove the visual experience. Colours, brightness and movement continue throughout, there is pressure and water running across the face, and there is the sensation of being worked on. Pain is unusual; discomfort is not.

Blood thinners are usually continued for drop-anaesthetic surgery, because the operation is nearly bloodless and stopping them carries its own risk. The rule for every medicine is the same: the doctor who prescribed it decides, together with the surgical team, and never a patient reading about it.

Inside the operation: phacoemulsification, step by step

The modern technique is phacoemulsification: breaking the lens up with ultrasound and aspirating the pieces. The sequence is the same in every routine case.

• The eye is dilated and cleaned. Drops widen the pupil over the preceding hour, and the lids and lashes are cleaned with antiseptic and held by a small clip, which does the blinking for you.
• A drape covers everything but the eye. This is the part claustrophobic patients dislike most. Air flows under it, and it can be lifted.
• Two tiny incisions are made at the edge of the cornea, self-sealing, which is why stitches are usually unnecessary.
• The front of the capsular bag is opened in a circle a few millimetres across, by hand or with a femtosecond laser. That opening holds the implant centred for the rest of the person’s life, so its size and shape matter more than its difficulty suggests.
• The lens is broken up and removed. Ultrasound emulsifies the hard central nucleus, the softer cortex is aspirated away, and the bag is left empty and clear.
• The implant is folded and injected through the same small incision, unfolds inside the bag and is positioned; a toric lens is then rotated to its pre-calculated axis.
• The eye is sealed and pressurised. The incisions are hydrated so they close themselves, and antibiotic is usually given inside the eye at the end.

A clear plastic shield is usually taped over the eye at the end, so vision is available immediately, blurred and bright.

The day itself, from arrival to going home

Cataract surgery is day surgery. People arrive a couple of hours beforehand, mostly for the dilating drops, which are the slowest step of the morning. Ordinary clothes are usual, and eating and drinking rules depend on whether sedation is planned.

In theatre the person lies flat on their back with the head supported. Lying flat and still for a quarter of an hour is the real physical requirement of the operation, and it is worth raising in advance for anybody with a bad back, a chronic cough or breathlessness lying down — practical problems with practical answers, usually a different anaesthetic plan or a tilt and extra pillows.

Afterwards there is a short recovery period, a drink, and drops with written instructions. Nobody drives themselves home. Vision immediately after surgery varies wildly and predicts nothing: some see clearly within hours, many see through frosted glass for a day or two, and both are ordinary. The course from there is set out under cataract surgery recovery, day by day.

One eye, then the other

When both eyes have cataracts they are almost always operated on separately, a short interval apart. The result of the first eye — where it landed relative to its target — refines the calculation for the second, which improves the aim. Operating one eye at a time also means that a complication, if one happens, can never affect both eyes in the same sitting.

The interval is usually between one and four weeks, and it is a clinical decision rather than a rule. Occasionally both eyes are done on the same day, under strict protocols with entirely separated instrument sets, where two anaesthetics or two journeys are a genuine problem — children under general anaesthesia, patients travelling long distances, some frail patients. It is an exception justified case by case, not a convenience.

Laser-assisted cataract surgery: what it changes, and what it does not

A femtosecond laser can perform some steps that were traditionally done by hand: opening the front of the capsular bag, making the corneal incisions, softening the lens by dividing it, and placing arc-shaped incisions to reduce astigmatism. The lens still has to be removed by ultrasound and aspiration, and the implant is still inserted by hand. The laser does not replace the operation; it automates part of it.

What it offers is reproducibility of the capsule opening and the incisions, and less ultrasound energy in dense cataracts. What it does not offer is a different category of result: in routine eyes with an experienced surgeon the practical difference for the patient is small. It is a tool with specific advantages in specific eyes rather than an upgrade everybody should buy.

The eyes in which cataract surgery is harder than usual

Most cataract operations are routine. The recognised difficult situations are known in advance, which is precisely why they are looked for.

• A pupil that will not dilate, after long-standing diabetes, previous inflammation, some prostate medicines or earlier eye surgery. Devices hold it open; the operation takes longer.
• Pseudoexfoliation and weak zonules. The threads suspending the lens can be fragile, leaving the bag unstable and sometimes calling for a support ring or a differently fixated implant.
• A very dense or white cataract, which takes more ultrasound and more time and gives a poor view, so the surgeon works with less information.
• A previously vitrectomised eye, in which the lens behaves differently under the instruments and the chamber is less stable.
• Previous refractive surgery, which leaves a cornea the standard power formulas were not designed for.
• A shallow front chamber or a very short eye, with less room to work in and less margin around the delicate inner surface of the cornea.

Every one has an established solution. What they change is planning, operating time and the frankness of the conversation about the likely result.

The risks of cataract surgery, stated plainly

Cataract surgery is among the most reliable operations in medicine, and it is still surgery inside an eye. The risks are individually small and entirely real, and they are not abolished by a good surgeon or a good hospital.

The complication that matters most is infection inside the eye, endophthalmitis. It is rare, it is why antibiotic is given at the end of the operation and drops afterwards, it is sight-threatening when it occurs, and it is treated as an emergency wherever in the world it happens.

During surgery the back wall of the capsular bag can tear, allowing vitreous gel to come forward — the classic intraoperative complication. It is managed at the time, the implant may be placed in a different position, and the eye usually still ends up seeing well, but recovery is longer and the risk of later problems, including retinal detachment, is higher than in an uncomplicated case.

Other recognised risks include bleeding, raised eye pressure early on, inflammation needing longer treatment, damage to the inner cell layer of the cornea where it was already marginal, an implant that ends up decentred or rotated, and retinal detachment months later, particularly in very short-sighted eyes. Dysphotopsia — arcs, crescents or rings of light at the edge of vision — is common early and settles for most people. Swelling of the cornea and of the central retina belongs to the recovery course rather than to a list of complications and is described under cataract surgery recovery, day by day; late clouding of the capsule is an expected event with its own treatment, set out under secondary cataract and YAG laser.

And there is the risk that owes nothing to surgical technique: the eye can be operated on perfectly and still see poorly, because the cataract was not the only problem. That is why the assessment beforehand matters more than the operation.

Cataract symptoms, and when surgery is worth it

Cataract symptoms arrive so slowly that most people cannot say when they started. That is the defining feature: a cataract does not hurt, does not make the eye red, and produces no single day on which vision changed. Sight is simply worse than it used to be, and the comparison that reveals it is usually accidental — covering one eye, failing an unexpected vision check, or noticing after the first eye is treated how yellow the world had become in the second.

What a cataract actually is

A cataract is a clouding of the eye’s natural lens. That lens is made of tightly packed proteins arranged so as to stay transparent; with time, and with certain exposures and diseases, the proteins clump, scatter light and turn yellow or brown. Nothing grows over the eye, there is usually nothing to see in a mirror, and it is not a film that can be peeled off — the change is inside the lens itself. That is why no drop, diet or exercise clears one, and why the only established treatment is to remove the lens.

Cataract is overwhelmingly a condition of ageing and eventually affects almost everybody who lives long enough. It usually develops in both eyes but rarely at the same rate, which is why one eye is often noticeably worse.

The cataract symptoms people notice first

• Blurring that glasses no longer fix. New spectacles help for a while, then stop. Frequent prescription changes are themselves a symptom.
• Glare and haloes around lights, worst at night. Oncoming headlights scatter into a starburst; wet roads become genuinely difficult.
• Colours going flat and yellow. Whites look cream, blues look grey. Almost nobody notices until the first eye is done and the two eyes disagree.
• Needing much more light to read, and finding restaurants, stairwells and dusk harder than the same tasks in daylight.
• A second image in one eye — ghosting produced by the lens itself, which is a different phenomenon from the double vision that comes from the two eyes pointing in different directions.
• Reading vision that improves for a time. Some cataracts make the lens more short-sighted, so someone who needed reading glasses for years suddenly reads without them. It is a change in the lens rather than a recovery, and distance vision deteriorates as it happens.
• Contrast disappearing. Faces are harder to read, kerbs and steps blend together, a room in soft light looks washed out. This is the symptom least captured by a letter chart and often the most disabling.

Why two people with the same cataract complain of opposite things

Cataracts do not all cloud the lens in the same place, and the location determines the symptom.

A nuclear cataract hardens and yellows the centre of the lens. It comes on slowly, dulls colour and contrast, and often shifts the eye towards short-sightedness — the source of the temporary reading improvement.

A cortical cataract forms spokes in the outer lens that point inwards. Its trademark is glare and light scatter, sometimes with vision that varies noticeably depending on light level.

A posterior subcapsular cataract sits at the very back of the lens, directly in the visual axis, and causes trouble out of all proportion to its size: bad glare, poor reading, and difficulty in bright light, because a constricted pupil in sunshine forces all the light through exactly the opacity in the way. It also progresses fastest, and is commoner in younger people, in diabetes, and after prolonged steroid treatment.

What makes a cataract form earlier than it should

Age is the main driver, but a cataract appearing in a fifty-year-old usually has a reason. Ultraviolet exposure over decades, smoking, diabetes, long-term steroid treatment in any form, a blunt or penetrating injury, previous surgery inside the eye — vitrectomy in particular — high short-sightedness and previous inflammation all bring it forward. Cataracts that are congenital or appear in childhood are a different clinical problem, handled under children’s eyes, because in a developing visual system the timing of treatment governs whether sight develops at all.

Waiting for a cataract to be “ripe” is an old rule

The idea that a cataract must mature before it can be removed belongs to an era of larger incisions and different technique. With phacoemulsification the opposite is closer to true: a very dense, white, over-mature cataract is harder to remove, needs more ultrasound energy, gives a poorer view during surgery and carries a higher chance of complication. There is nothing to be gained by waiting until sight is severely impaired, and something to lose. That is not an argument for removing every cataract the moment it is seen; it removes the artificial reason for waiting and leaves the real question in the open.

When surgery is worth it: function, not a line on a chart

The honest answer to “when is it time” is not a measurement. It is whether the cataract has taken away something the person wants back. A retired reader who no longer enjoys books, a driver who has quietly stopped going out after dark, a grandparent who cannot see faces at the far end of a table — all may have very different letter-chart scores, and all have a reason to operate. Someone who reads, drives and works comfortably has no reason to operate on a lens simply because it has begun to yellow.

Two situations do let the chart decide. The first is legal: driving standards are set by the country where the licence is held, and are measured rather than negotiated. The second is medical: occasionally a swollen cataract raises pressure inside the eye or blocks the view of a retina that needs monitoring, and then the lens is removed for the eye’s sake rather than for comfort.

The chart also systematically underestimates cataract, because it is read in high contrast, in controlled light, without oncoming headlights. Glare and contrast testing come far closer to what the person is actually experiencing, which is why a good eye on paper and a poor eye at night are not a contradiction.

When the cataract is not the reason vision is poor

A cataract can coexist with anything, and the eyes most likely to have one are also the eyes most likely to have something else. Macular degeneration, diabetic damage to the retina, glaucomatous loss of the optic nerve and long-standing amblyopia all reduce vision in ways that removing a lens cannot restore. In those eyes the cataract is still worth removing when it adds its own obstruction, because the gain in brightness and contrast is real — but the ceiling belongs to the other disease. Establishing that ceiling beforehand is why the retina and optic nerve are examined before surgery is offered, and why a careful unit sometimes gives a far more cautious prediction than the cataract alone would suggest.

Choosing the lens: monofocal, multifocal, toric

Cataract surgery lens options are simpler than the marketing suggests. Every implant is a permanent artificial lens placed inside the capsular bag; what varies is how many distances it focuses at once, and whether it corrects astigmatism. No implant gives a sixty-year-old the eye of a twenty-year-old, so the honest way to choose is to decide which compromise suits a particular life.

What every implanted lens does, and what none of them do

An intraocular lens replaces the focusing power of the natural lens and is calculated to bring the eye into focus at a chosen distance. What none of them do is accommodate the way a young natural lens does, changing shape continuously to shift focus from far to near. Every current implant simulates near vision by some other means — splitting light between focal points, stretching the depth of focus, or setting the two eyes to different distances — and each method costs something.

All implant types go in through the same incision in the same operation. Choosing a more complex lens changes nothing the patient experiences on the day; it changes the measurement demands beforehand and the tolerance for anything less than a perfect result afterwards.

Monofocal lenses: the predictable default

A monofocal lens focuses at one distance, almost always set to far, so distance vision is sharp without glasses and reading glasses are worn for close work. It is the most forgiving choice in existence: contrast is excellent, night vision is unaffected, it behaves predictably in eyes with other problems, and a small error in the calculated power is easily corrected with a thin spectacle lens.

It is the right lens for most eyes and emphatically not a lesser option: anyone happy in reading glasses, anyone who drives at night for a living, and anyone whose macula or optic nerve is less than perfect is usually better served by a monofocal than by anything more elaborate. It can also be aimed at near instead, which suits a lifelong short-sighted person who has always read unaided and would rather wear glasses for distance.

Toric lens implants for astigmatism

A toric lens corrects astigmatism, which is a cornea shaped more like a rugby ball than a football. Astigmatism is not fixed by removing a cataract; if it is significant and left untreated, the eye needs glasses for every distance regardless of how well the surgery went.

A toric lens has more power in one meridian than the other, and must be rotated to a precise axis during surgery and stay there. That is its one vulnerability: if it rotates in the bag afterwards the correction degrades, and a significant rotation is dealt with by repositioning it in a short second procedure. Toric correction is available in monofocal, extended depth of focus and multifocal designs, so it is a property added to a lens rather than a category of its own. Astigmatism can alternatively be reduced with arc-shaped incisions in the cornea at the time of surgery, or with laser afterwards, depending on how much there is and how regular it is.

Multifocal lens implant: what it buys, and what it costs

A multifocal lens implant splits incoming light between two or more focal points, so a far image and a near image are projected onto the retina at once and the brain learns to attend to whichever is in use. It buys the thing people want most: a realistic chance of getting through an ordinary day without reaching for glasses.

What it costs is stated too rarely. Splitting light means less light in each image, so contrast is lower than with a monofocal — most noticeable in dim conditions. Rings and haloes around lights at night, and starbursts around headlights, are an expected consequence of the design, not a fault. Most people adapt over months as the brain learns to suppress the out-of-focus image; a minority never do, and for them the options are spectacles for night driving or, rarely, exchanging the lens.

The other cost is a loss of tolerance. A multifocal lens demands that the power calculation, the centration and the ocular surface all be close to perfect, because it has no spare contrast to give away. A small residual refractive error a monofocal patient would never notice is obvious through a multifocal. The candidates who do best have healthy eyes, realistic expectations, a strong wish to be free of glasses, and a temperament that adapts rather than scrutinises — a point that sounds unscientific and is the observation most experienced surgeons trust most.

Extended depth of focus lenses, in between

Extended depth of focus designs stretch a single focal point into a longer range rather than splitting light into separate images. They give good distance and intermediate vision — screens, dashboards, faces across a table — with better contrast and fewer night-time haloes than a full multifocal, at the cost of usually still needing glasses for small print. They suit people whose complaint is the computer and the car rather than the paperback.

Monovision: one eye set for distance, one for near

Monovision uses two ordinary monofocal lenses aimed at two different distances: the dominant eye for far, the other for near or intermediate. The brain suppresses the blurred image and uses whichever eye is in focus. It costs nothing in contrast, keeps night vision clean, and uses the most predictable implant available.

The cost is depth perception and a period of adaptation. A full monovision difference is not tolerated by everybody, which is why a smaller one — mini-monovision, or blended vision — is more commonly used: less near vision gained, far more people comfortable with it. Monovision also has an advantage no other strategy has: it can be trialled in advance with contact lenses, so the person experiences it before anything permanent is done.

The eyes a multifocal lens is wrong for

A unit that fits multifocal lenses to everybody who asks for one is not doing its job. The reasons to decline are specific.

• Macular disease of any significant degree, including early macular degeneration and diabetic changes: the lens removes contrast from an eye that already has too little.
• Advanced glaucoma, for the same reason applied to the optic nerve.
• An irregular cornea — keratoconus, scarring, or past corneal surgery — because the optical quality the design depends on is not there.
• Untreated or severe dry eye, which destabilises vision moment to moment and makes the measurements less reliable.
• Occupational night driving or precision night work. The haloes are not a defect to complain about afterwards; they are part of the specification.
• A pupil, a zonular weakness or a capsule that makes perfect centration unlikely, since the design depends on the lens sitting exactly where it was planned to sit.
• Expectations that cannot be met. Wanting perfect vision at every distance in every light describes something no implant provides.

Getting the power right, and what happens when it lands off target

The implant power is calculated from the biometry performed before surgery. Modern formulas are good, and the eye still has variability no formula removes: the final position the lens settles into inside the capsular bag can be predicted but not measured in advance. So a proportion of eyes end up slightly away from their intended target, usually by an amount easily handled with a thin spectacle lens. Eyes at the extremes of length, and eyes with previous laser vision correction, are the least predictable, and the conversation beforehand should say so rather than quote a precision that does not apply to that eye.

When a result does land meaningfully off target there are three established routes: spectacles or contact lenses; laser vision correction on the cornea once the eye has settled; or exchanging the implant, the largest option and the least often needed. An off-target result is solvable rather than permanent — but every solution is a further procedure, which is why the measurement appointment deserves the seriousness it gets.

Cataract surgery lens options side by side

Lens type	What it does	Glasses afterwards	Main trade-off	Typically suits
Monofocal	One focal distance, almost always set for far.	Reading glasses for close work.	No near vision unaided — in exchange, the best contrast and the most predictable result of any implant.	Most eyes; particularly retinal or optic nerve disease, heavy night driving, and anyone content in reading glasses.
Toric (added to any of the others)	Corrects corneal astigmatism as well as focusing power.	Depends on the base lens; without it, glasses at every distance.	Must be rotated to a precise axis and stay there; rotation degrades the correction.	Anyone with significant regular astigmatism, whatever else they choose.
Extended depth of focus	Stretches one focal point into a range covering far and intermediate.	Usually glasses for small print, often none for screens and driving.	Less near vision than a multifocal; some contrast loss, though less than a multifocal.	Screen and dashboard lives; less dependence on glasses without giving up night driving.
Multifocal	Splits light between two or more focal points, focusing far and near at once.	Often none for most of the day, for people who adapt well.	Reduced contrast, haloes and starbursts at night, a real adaptation period, no tolerance for residual refractive error.	Healthy eyes, a strong wish for spectacle independence, expectations that absorb the night-time optics.
Monovision (two monofocals, different targets)	One eye aimed far, the other near or intermediate; the brain uses whichever is in focus.	Often none routinely; glasses for prolonged near work.	Reduced depth perception and an adaptation period; not tolerated by everybody.	People who have already worn monovision contact lenses successfully.

The same lens decision, made before a cataract has formed, is what refractive lens exchange consists of — the identical operation with the identical implant choices, performed earlier and for a different reason.

Cataract surgery recovery, day by day

Cataract surgery recovery is unusual in being fast at the beginning and slow at the end. Most of the useful vision returns within the first few days, and then the eye keeps quietly changing for weeks — settling its focus, clearing its residual swelling, and finishing the healing that decides the final spectacle prescription. Knowing which part of that curve you are on prevents most of the anxiety.

Two caveats belong at the start. Recovery varies between people and between eyes, and a dense cataract, a long operation or a complication all lengthen it. And the protocol — how many drops, for how long, when the checks happen — belongs to the operating team, whose instructions supersede any general description of the usual pattern.

The first hours of cataract surgery recovery

The eye is numb for a few hours and then wakes up. What most people feel as the anaesthetic wears off is grittiness, as though sand or an eyelash were in the eye, with watering and light sensitivity. That comes from the tiny incisions at the edge of the cornea and is the ordinary experience of the first evening; simple pain relief handles it in the great majority of cases.

Vision in the first hours is unreliable and predicts nothing. The pupil is still widely dilated, so everything is dazzling, and if an anaesthetic injection was used vision may be greyed out for an hour or two. Colours are usually the first thing noticed — whites suddenly white, blues suddenly blue — because the yellow filter has gone. A shield is usually worn over the eye at night for the first week or so; rubbing is the one mechanical thing that matters early on, because the incisions seal themselves rather than being stitched.

Day one: the check, and the first clear look

A check the day after surgery, or within the first few days, is standard. It measures vision, looks at the position of the implant, examines the incisions and checks the pressure inside the eye. It is short, and it is where most people first find out how the eye is really doing.

By day one, vision in an uncomplicated eye is often already better than before surgery, though frequently hazy. That haze is usually corneal swelling from the ultrasound energy used during surgery, and it clears over days. Reading is often poor at this stage even in eyes destined to read well, because the eye is still swollen and the prescription is meaningless. A headache-like ache around the brow is common, as is a red patch on the white of the eye where an instrument or the clip pressed — a bruise that looks alarming and behaves like a bruise anywhere else, fading over a week or two.

Days two to seven after cataract surgery

This is the week in which most of the visible improvement happens. Grittiness fades, watering settles, and light sensitivity decreases but usually lingers a couple of weeks. Most people are reading large print, watching television and moving around normally within the first days. Desk work is commonly resumed within a few days and physical work later, the timing set by the operating team according to what the job involves.

Two visual oddities belong to this week and worry people unnecessarily. The first is a dark crescent or shadow at the outer edge of vision, most obvious in bright light — negative dysphotopsia, caused by the edge of the implant, which fades for the overwhelming majority over weeks to months. The second is haloes or arcs around lights at night, which occur with all implants and are more prominent with multifocal designs.

Floaters are often noticed for the first time after surgery, not because they are new but because a clear lens makes them visible. New floaters accompanied by flashes of light are a different matter and are described under floaters and flashes.

Weeks two to four: the eye that keeps changing

By the second week the eye usually feels normal and most restrictions have gone. Vision is good but not yet fixed: it fluctuates through the day and is affected by dryness far more than people expect. Dryness after cataract surgery is very common — the incisions temporarily disturb the corneal nerves, and the drops themselves contribute — and it is the commonest reason for the complaint that vision is “not stable yet”.

For anyone waiting on a second operation, it is also the period in which the mismatch between the two eyes is at its most awkward.

Four to six weeks: when the prescription settles

The eye is generally considered stable enough for a new spectacle prescription at around four to six weeks, once the drops have finished and the swelling has resolved. Glasses ordered earlier are frequently wrong within a fortnight, which is an expensive way to learn about corneal healing. In the meantime old spectacles are usually unusable for the operated eye, and many people simply pop the lens out of an old frame or use inexpensive off-the-shelf readers.

What the final prescription looks like depends entirely on the lens strategy chosen, which is set out under choosing the lens. A distance-targeted monofocal eye needs reading glasses; that is the plan working, not a failure of the surgery.

The drops, as a principle rather than a schedule

Everyone goes home with eye drops, typically an antibiotic for a short period and an anti-inflammatory for longer, tapering as the eye settles. The medicines, frequency and duration are set by the operating team, and the only rule safe to state generally is this: the drops are part of the operation rather than an optional extra, and the team that prescribed them decides when they stop.

Three practical points hold regardless of the schedule. Drops instilled too close together wash each other out, and the eye holds only a fraction of a single drop — which is why the operating team’s written instructions cover the order and the spacing as well as the bottles. And a dropper tip touching the eye or the lashes is contaminated, which is the one hygiene point worth being fussy about. Preservative-free artificial tears are frequently added alongside, since dryness accounts for much of the early visual fluctuation.

Corneal oedema (corneal edema) and macular oedema (macular edema)

Two kinds of swelling shape the recovery, and neither is a complication in the ordinary sense.

Corneal edema is swelling of the clear front window, caused by the energy and fluid movement of the surgery itself. It is what makes vision misty in the first days, and it resolves as the inner cell layer of the cornea pumps the fluid back out. Where that cell layer was already weakened — Fuchs’ dystrophy, a very dense cataract, a long operation — the corneal edema takes longer to clear, and occasionally does not clear fully, which is when a corneal procedure is later considered.

Macular edema is swelling at the centre of the retina, and behaves completely differently. It appears not in the first days but typically some weeks afterwards, and its signature is an eye that saw well and then quietly became blurred or distorted again. It is picked up on an OCT scan and treated with drops in the first instance, and it is more likely in eyes with diabetes, previous retinal vein problems, previous inflammation, or after a complicated operation. Most cases resolve with treatment; a few are stubborn. The practical point is that a delayed drop in vision weeks after surgery has a specific, recognised, treatable explanation and is not the implant failing.

Normal healing, and the two conditions that do not belong to it

Normal is a gritty, watery, light-sensitive eye that improves day by day; a red patch on the white; a mild ache; fluctuating vision; new awareness of floaters; and haloes at night that lessen with time.

Endophthalmitis — infection inside the eye — runs the opposite course to healing: pain that increases rather than settles, vision that falls rather than rises, spreading redness and growing light sensitivity in the days after surgery. It is rare, it moves quickly, and it is treated as an emergency in hospital. A retinal tear or detachment after cataract surgery presents differently again, with a shower of new floaters, flashing lights or a curtain across part of the field, and is repaired urgently in hospital. Both are recognised conditions in their own right rather than variations of normal healing.

The second eye, and the strange interval in between

The weeks between the two operations can be visually uncomfortable. One eye is now clear, bright and blue-tinged while the other is still yellow and dim. If the operated eye was short-sighted and has been aimed at distance, the two are also focused at different places, and a spectacle lens correcting the unoperated eye can make the mismatch worse rather than better. Some people manage by removing the lens for the operated eye from their frame; others use a temporary contact lens in the other. The compensation is that where the first eye landed relative to its target is fed back into the calculation for the second.

Work, exercise, swimming, flying and driving

The general principle for the first weeks is that anything pushing water, dirt or pressure into a healing eye waits, and everything else does not.

• Reading, screens, television, walking and light activity from the first day. Using the eye does not damage it and there is no need to rest it; bending and lifting are usually restricted briefly, and the team sets that limit.
• Showering and washing straight away, keeping soapy water and shampoo out of the eye and not rubbing the lid.
• Swimming pools, hot tubs, saunas and open water wait several weeks, because they are the classic route for contamination through an incision that is sealed but not yet strong.
• Eye make-up, and dusty or heavy manual work, wait until the team says the surface has healed; old mascara is replaced rather than reused, and protective eyewear is worn on return to dirty work.
• Flying is not restricted by routine cataract surgery, unlike retinal surgery involving a gas bubble, where the rule is absolute and is covered under vitrectomy.
• Driving resumes when vision meets the legal standard where the licence is held and the operating team is satisfied, which for most uncomplicated eyes is within days. Night driving often feels worse than day driving for the first weeks, because of haloes and light sensitivity.

Secondary cataract and YAG laser

Secondary cataract is the name given to a clouding that develops months or years after successful cataract surgery, and it is one of the most misleadingly named conditions in medicine. It is not a cataract, and it is not the old one returning. The natural lens was removed and cannot grow back. What has clouded is the thin membrane left behind to hold the implant in place.

Why “my cataract has come back” is the wrong description

The confusion is understandable, because the symptoms are almost identical to the original cataract. Somebody who spent years watching their sight fade, had it restored, and is now watching the same thing happen again has every reason to fear the worst.

The reassuring part is structural. The implant is unaffected and does not deteriorate, so whatever vision the eye achieved after the original surgery is recoverable — the obstruction is a membrane in front of the implant rather than a change in the eye’s optics — and the treatment is a laser procedure taking a few minutes in a clinic room, without an incision.

Posterior capsular opacification: what actually clouds

The clinical name is posterior capsular opacification. During cataract surgery the lens material is removed and the capsular bag that contained it is deliberately left in place, because it is the ideal housing for the implant. A few natural lens cells always remain at the edges of that bag — no technique removes every one — and over time they migrate across the back wall and multiply, forming a layer that scatters light before it reaches the retina. Sometimes they form a wrinkled, translucent sheet, sometimes clusters resembling small pearls. Either way the effect is like looking through a fogged window at a lens that is otherwise perfect.

This is an expected long-term consequence of the way the operation is done rather than a complication or an error. It is not caused by rubbing the eye, by using the eye too much, by a poor operation, or by anything the patient did. It is commoner in younger patients and in eyes with diabetes or previous inflammation, and it varies with implant design and material.

Secondary cataract symptoms, and when they appear

The complaints that bring somebody back with a secondary cataract are consistent:

• Gradual blurring in an eye that had been seeing clearly.
• Glare around lights.
• Reduced contrast.
• Colours flattening again.

The timing is what distinguishes it. Vision after cataract surgery improves and stabilises within weeks; posterior capsular opacification typically appears months to years later, in an eye that had been seeing well in the interim. The decline is gradual, and the eye itself stays white and comfortable throughout. Glare is often the first complaint, particularly at night and when driving into low sun, because a cloudy capsule scatters light exactly as a cataract does, and reading becomes harder. People with multifocal implants notice it earlier and more intensely, because their lens design has less contrast to spare.

Treatment is offered on the same principle as the original surgery: when the clouding interferes with what the person needs to do, not when it becomes visible on examination. A capsule just beginning to cloud in someone seeing perfectly well is watched.

YAG laser capsulotomy: what the treatment is

YAG laser capsulotomy uses a precisely focused laser to make an opening in the clouded back wall of the capsule, directly in the line of sight. The laser does not remove the membrane; it divides it, and the fragments retract out of the visual axis, leaving a clear circular window through which light reaches the retina unobstructed. Nothing enters the eye: no incision, no injection, no stitch, no general anaesthetic. The person sits at a machine resembling the one used for a routine eye examination, and it takes a few minutes.

What the treatment day is like

Dilating drops are given first and take up most of the visit. Anaesthetic drops numb the surface, and a contact lens is usually placed on the eye to hold the lids open and focus the laser accurately — the sensation is pressure and a lens resting against the eye rather than pain. The laser produces a series of audible clicks and small flashes of light, and the commonest description is that the noise is more startling than anything felt. The eye is not covered afterwards, and the pupil stays dilated for several hours, so bright light is uncomfortable and driving straight afterwards is not possible.

Vision is commonly clearer the same day and sharpens over a day or two as the drops wear off and debris settles. A short course of anti-inflammatory drops is often prescribed, and the pressure inside the eye is checked afterwards, since a temporary rise is the recognised early effect. New floaters are very common in the first weeks — small fragments of capsule drifting in the vitreous — and usually become unnoticeable with time.

The risks of YAG laser capsulotomy, and why timing matters

The procedure is quick and well tolerated, and it still carries recognised risks that make it a treatment rather than a formality. Pressure inside the eye can rise afterwards, which is why it is measured. Inflammation can follow and is treated with drops. The laser can leave small pit marks on the implant, usually visually irrelevant. Swelling at the centre of the retina can occur, as after any procedure inside the eye. And there is an increased risk of retinal detachment, small in absolute terms but higher in very short-sighted eyes and after a complicated cataract operation — one reason a capsulotomy is not performed simply because a capsule looks cloudy.

Timing matters for a second reason. Once the back of the capsule is open, the compartment behind the implant is in continuity with the vitreous cavity, and any future exchange or repositioning of the implant becomes a considerably larger undertaking. Where there is a realistic prospect the implant may need changing — a multifocal lens the patient has not tolerated, or a lens that ended up substantially off target — the sequence is deliberately reversed, and the lens question is settled before the capsule is opened.

Once performed, the opening is permanent: the capsule does not re-cloud across a completed capsulotomy, so this is a once-per-eye treatment. Anybody told they need it repeatedly is being told about something else.

When the clouding is not the capsule

Vision that deteriorates years after cataract surgery is not always the capsule, and a laser aimed at the wrong problem simply wastes a procedure. The same slow decline in a quiet, white eye is produced by macular degeneration, by diabetic changes at the centre of the retina, by glaucoma quietly removing peripheral vision, by corneal decompensation in an eye whose inner cell layer was marginal to begin with, and by a straightforward change in spectacle prescription. Distortion of straight lines in particular points at the macula rather than the capsule. Telling them apart is why the eye is examined and scanned before a capsulotomy is offered.

Laser vision correction (laser eye surgery)

Laser eye surgery reshapes the cornea — the clear front window of the eye — so that light focuses on the retina without help from glasses or contact lenses. Laser vision correction is the umbrella term for the three ways of doing it: LASIK, surface laser (PRK and its variants) and SMILE. They differ in how the laser reaches the tissue it reshapes, and in what that difference costs in comfort and healing time. What they share matters more than what separates them. All three treat a shape problem. All three work by removing tissue, never by adding it. And none of them stops the eye ageing.

That last point is the one most often lost in the marketing. Laser correction changes the prescription in front of the eye; it does not change the eye. An eye treated at thirty still develops presbyopia in its forties and a cataract in its sixties, and a treated short-sighted eye is still a long eye with a stretched retina.

Which is appropriate is decided by the cornea and the prescription, and the lens-based alternatives are set out under implantable lenses and refractive lens exchange.

What laser eye surgery actually changes

Two thirds of the eye’s focusing power sits in the cornea, not in the lens. A prescription is, in optical terms, a mismatch between that focusing power and the length of the eyeball. Short sight means the eye focuses light in front of the retina; long sight means it focuses behind it; astigmatism means the cornea is shaped more like the back of a spoon than a section of a sphere, so light focuses at two different points instead of one.

The excimer laser corrects each of these by removing corneal tissue in a mapped pattern, a fraction of a micron at a time, with a cold ultraviolet beam that breaks molecular bonds rather than burning. For short sight it flattens the centre; for long sight it removes a ring in the mid-periphery so the centre becomes relatively steeper; for astigmatism it removes tissue asymmetrically. The femtosecond laser does a different job — it does not reshape, it cuts, creating the LASIK flap or carving the lenticule removed in SMILE.

The depth of tissue removed rises with the strength of the prescription and with the width of the treated zone. That arithmetic is behind almost every restriction in refractive surgery: a strong prescription in a thin cornea asks for more tissue than the eye can safely give. The rules following from it are set out under who laser correction suits.

What the assessment involves before any laser

The refractive work-up is not a formality before a decision that has already been made. It is the decision. A proper assessment takes a couple of hours, usually across more than one visit, and includes:

• The measurements that decide yes or no — corneal map, thickness, tear film, retina and optic nerve. What each one has to show is set out under who laser correction suits, and who it does not.
• Manifest and cycloplegic refraction. The prescription measured both normally and with the focusing muscle relaxed by drops. In younger eyes the two figures can differ substantially, and treating the wrong one produces an overcorrection that shows up years later.
• Pupil size in dim light. A pupil that opens wider than the treated optical zone is the best single predictor of night-time glare.
• Baseline eye pressure and optic nerve assessment, which stay clinically useful for the rest of the patient’s life, for reasons set out under the risks of laser correction.

One part of the preparation is routinely underestimated: the contact lens holiday. Lenses mould the cornea, and a moulded cornea produces a distorted map. Soft lenses come out for a period beforehand, rigid gas-permeable lenses for considerably longer, and the map is repeated until two consecutive measurements agree. A patient still wearing lenses in the week of surgery is not being screened — they are being screened on the wrong cornea.

The day of laser surgery

Laser correction is day surgery. The patient walks in, is awake throughout and walks out. There is no injection and no general anaesthetic for a routine case.

Anaesthetic drops numb the surface completely; the eye can feel pressure but not pain. A small clip holds the lids open, which sounds worse than it is and removes the worry about blinking. The eye looks at a target light. During flap creation in LASIK, and during the lenticule cut in SMILE, a suction ring holds the eye still and raises the pressure inside it for a few seconds — vision dims to grey or black, then returns. It is the part patients remember, and it is brief.

During excimer treatment there is a rhythmic clicking and a faint, distinctive smell, which is the tissue being vaporised. Treatment takes seconds to tens of seconds per eye, and both eyes are usually done in the same session. Vision immediately afterwards is hazy and watery, like looking through a steamed window, and the eye is light-sensitive. Patients do not drive themselves home. Shields are worn for sleeping in the first nights so the eye cannot be rubbed unconsciously.

What laser correction does not fix

Being clear about the boundaries is part of the consent, not a caveat added afterwards.

• Reading vision after the mid-forties. Presbyopia comes from the natural lens stiffening, not from the cornea. Correcting both eyes fully for distance in a presbyopic patient reliably produces good distance vision and a need for reading glasses. The alternatives are set out under refractive lens exchange.
• Cataract. The natural lens still clouds with age, and it is still removed by cataract surgery when it does. Previous laser treatment makes the lens power calculation harder, which is why the pre-laser measurements are kept.
• The retinal consequences of a myopic eye. Retinal thinning, lattice degeneration and the lifetime risk of retinal detachment belong to the length of the eyeball. They are unchanged by anything done to the cornea.
• Glaucoma. Laser correction neither causes nor prevents it, but it does interfere with how eye pressure is measured afterwards — see what the pressure number means.

LASIK cost: what a quoted price is actually made of

LASIK cost is one of the most searched things about the procedure and one of the least comparable. Quoted figures differ between countries, between clinics in the same city, and between two quotes from the same clinic, because they are not describing the same package. Rather than publish a number that means nothing without its contents, it is more useful to set out what a price consists of.

• The assessment. A full tomography-based work-up with repeated measurements costs more to deliver than a brief screening on a single machine, so it is worth knowing which tests a headline figure contains.
• The platform. Femtosecond flap creation, the various ablation profiles and lenticule extraction are not interchangeable technologies and are not priced alike.
• Both eyes, or one. Some quotes are per eye and some are per patient, which changes the total by a factor of two.
• Follow-up and medication. How many post-operative visits are included, and whether drops are, varies widely. Follow-up after surface laser runs longer than after LASIK because the healing does.
• The enhancement policy. Whether a second treatment is included, for how long and on what conditions, is the largest hidden variable — and, as set out under the risks of laser correction, an enhancement is not always possible even when it is free.

A cheaper quote is not necessarily a worse operation, and an expensive one is not a guarantee of anything. But price is the wrong variable to optimise when candidacy is marginal, because the cases that end badly are almost never the ones where the wrong laser was used — they are the ones that should not have been treated at all.

LASIK, PRK and SMILE compared

LASIK, PRK and SMILE reshape the same tissue with the same physics. The difference is access: how the laser reaches the layer it removes, and what has to be done to the surface of the eye to get there. That single difference drives everything patients actually care about — how much it hurts, how fast they see, what can go wrong, and what happens if a second treatment is ever needed.

How the three procedures differ

Procedure	Flap	How the laser reaches the tissue	The first few days	When vision becomes useful	Suits	Less suitable for
LASIK (usually femto-LASIK)	Yes — a hinged flap of the outer cornea is lifted and replaced	Femtosecond laser makes the flap; excimer laser reshapes the bed underneath; the flap is laid back down	Comfortable. Watering and light sensitivity for a few hours, then largely settled	Fast — most people see usefully the next day	Most standard prescriptions in a cornea of adequate thickness and a normal map; people who need to be functional quickly	Thin corneas, borderline topography, marked dry eye, contact sports and jobs with a high risk of blows to the face
PRK / surface laser (also LASEK, trans-PRK)	No — the surface skin layer is removed and regrows	The epithelium is removed, the excimer laser reshapes the exposed surface directly, a bandage contact lens is placed	Genuinely uncomfortable. Aching, grittiness and light sensitivity for several days while the surface heals over	Slow — blurred for days, refining over weeks, and high corrections can take months to settle fully	Thinner corneas, mild map irregularity, deep-set eyes, and anyone whose work or sport makes a flap a liability	Anyone who cannot accept several days out of action, and who cannot tolerate a slow visual recovery
SMILE (lenticule extraction)	No — a small incision only	Femtosecond laser carves a disc of tissue inside the intact cornea; it is drawn out through an incision of a few millimetres; no excimer laser is used	Comfortable. Similar to LASIK, sometimes with a little more early haze	Fast, though often a day or two behind LASIK in the first week	Short sight with or without astigmatism, particularly where dry eye or a flap is a concern	Long sight and mixed astigmatism in most hands; very low prescriptions; anyone whose enhancement path needs to be simple

LASIK vs PRK: the flap is the whole argument

LASIK vs PRK is the oldest comparison in refractive surgery and it comes down to one structural choice. LASIK creates a hinged flap, treats the tissue underneath, and puts the flap back — so the eye’s surface skin layer is never broken across the treated zone, and comfort and vision return quickly. PRK surgery does the opposite: it removes that surface layer entirely, treats the cornea directly, and lets the layer grow back over the following days under a bandage contact lens.

The consequences follow logically. LASIK buys speed and comfort at the price of a permanent interface inside the cornea — a plane that never regains full tensile strength and brings its own small set of complications. PRK avoids that interface entirely, at the price of several days of real discomfort and weeks of unstable vision.

PRK surgery: when surface laser is the better choice

PRK surgery is chosen over LASIK, not merely tolerated, in several situations:

• Thin corneas. A flap consumes thickness that then cannot be used for treatment. Surface laser spends none of it.
• Maps that are not perfectly regular. Where the topography is unremarkable but not pristine, surface treatment is the more conservative option — and sometimes the correct answer is neither, as set out under candidacy.
• Occupations and sports with impact risk. Contact and combat sports, martial arts, military and some police roles. A flap can be displaced by a blow years later; a surface-treated cornea has nothing to displace.
• Previous corneal surgery or scarring, where lifting a flap through altered tissue is unpredictable.

The drawback specific to surface laser is haze, a fine scarring response in the healing surface, described under the risks of laser correction. Its bearing on this choice is that very high corrections are often better served by a lens-based option than by surface treatment.

LASIK vs SMILE: no flap, but a different enhancement path

LASIK vs SMILE is the newer comparison and a genuinely close one. SMILE keeps the strong outer layers of the cornea intact apart from a small incision, so it avoids flap displacement altogether and cuts fewer corneal nerves in the process. Less nerve disruption tends to mean less dry eye in the early months, which is the most common complaint after LASIK and the reason SMILE is often preferred in patients whose tear film is already borderline.

Against that sit three honest limitations. SMILE principally treats short sight, with or without astigmatism; long sight and mixed astigmatism remain the territory of LASIK and surface laser in most hands. Very low prescriptions produce a lenticule too thin to handle reliably. And the enhancement path differs: with no flap to lift, a second treatment after SMILE is usually done as a surface ablation or by creating a flap at that later stage. Neither is a problem, but the simplest re-treatment route belongs to LASIK.

Visual recovery after SMILE is fast but characteristically a little behind LASIK in the first days, often continuing to sharpen over the first weeks.

SMILE eye surgery, step by step

SMILE eye surgery — small incision lenticule extraction — uses only one laser. There is no excimer stage at all.

A suction interface docks onto the eye and holds it still; vision greys out for the seconds this takes. The femtosecond laser then fires a dense pattern of microscopic bubbles inside the cornea, tracing out a contact-lens-shaped disc of tissue — the lenticule — together with a small tunnel to the surface, typically a few millimetres wide. The suction releases. The surgeon separates the lenticule at its two planes with a fine instrument and draws it out through the incision in one piece. The cornea, now thinner by exactly the shape that was removed, settles into its new curvature. The incision needs no stitch.

Because the removed tissue comes out as a single physical object rather than being vaporised, there is no exposed bed drying during treatment — and the procedure is correspondingly less forgiving of an incomplete separation, since the lenticule has to come out whole.

Where the procedure names get confusing

Refractive surgery has more brand names than it has procedures, and the marketing layer causes real confusion.

• Femto-LASIK, IntraLASIK, all-laser LASIK, bladeless LASIK all mean the same thing: LASIK with the flap made by a femtosecond laser rather than a blade.
• PRK, LASEK, epi-LASIK and trans-PRK are all surface laser, differing only in how the epithelium is removed — scraped, loosened with dilute alcohol, lifted mechanically, or vaporised by the laser in a single step. The reshaping and the recovery are essentially the same.
• Wavefront-optimised, wavefront-guided and topography-guided are ablation profiles, not procedures, and any of them can be delivered as LASIK or as surface laser.
• ReLEx SMILE and similar names describe lenticule extraction on particular laser platforms.

The useful question is never which brand name is on the brochure. It is which of the three access routes — flap, surface or lenticule — suits the cornea being treated.

Implantable lenses (ICL)

ICL surgery corrects a prescription by placing a thin, permanent lens inside the eye rather than by removing corneal tissue. The implantable collamer lens sits behind the iris and in front of the eye’s own natural lens, which stays exactly where it is. Nothing is subtracted from the cornea, so the cornea’s thickness and shape are preserved, and the correction is in principle reversible: the lens can be removed or exchanged.

That makes ICL the standard answer for the eyes laser cannot treat safely — very high short sight, corneas too thin for the tissue a laser correction would require, borderline maps, and significant dry eye.

What an implantable collamer lens is

The implantable collamer lens is made of collamer, a soft copolymer containing collagen, which the eye tolerates without recognising it as foreign. It is flexible enough to be folded and injected through an incision of about three millimetres, and it unfolds inside the eye into a shape a little larger than the pupil, with four haptics that rest in the groove behind the iris.

It is not visible to other people and not felt by the patient. It needs no cleaning and no maintenance, and most models include a small central port that lets fluid circulate through the lens rather than only around it. Because it adds a lens rather than flattening a cornea, it does not induce the optical side effects that come from reshaping the corneal surface — which is why the quality of vision at high prescriptions is often better than an equivalent laser correction would give.

Who ICL surgery is for

• High short sight beyond the safe reach of laser, where the tissue a laser would need to remove exceeds what the cornea can spare whatever its starting thickness.
• Thin corneas, where pachymetry rules out LASIK and sometimes surface laser too.
• Borderline or irregular topography, in an eye that is not frankly keratoconic but is not a safe candidate for tissue removal either — see keratoconus.
• Established dry eye. ICL does not cut corneal nerves across the optical zone, so it does not carry the post-laser dry eye pattern described under the risks of laser correction.
• Patients who want the option of reversal. Removing an ICL restores the eye to roughly its pre-operative state; removing corneal tissue is permanent.

Anatomy sets its own limits. There has to be enough space between the iris and the natural lens to seat the implant, and enough healthy corneal endothelium — the single cell layer that keeps the cornea clear — to tolerate a lens inside the eye for decades. Both can rule the procedure out.

What ICL surgery involves

The measurement stage is more involved than for laser, because the implant is manufactured to the individual eye. Alongside the prescription, the assessment measures the horizontal corneal diameter, the depth of the anterior chamber and the dimensions of the space the lens will occupy, and counts endothelial cell density. The lens is then ordered in a specific power and length, and manufacturing and delivery take time — a practical point addressed under coming from abroad, since it means ICL cannot be assessed and implanted within a single short trip.

The operation itself is short and is done under local anaesthesia (anesthesia): drops numb the eye, the patient is awake, and there is no injection behind the eye for a routine case. The pupil is dilated, a small incision is made at the edge of the cornea, and the folded lens is injected and tucked behind the iris into position. The incision is self-sealing. The eye and its pressure are checked the same day or the next, because the early hours are when a pressure rise would show. The second eye is usually done a short interval later rather than at the same sitting, though practice varies between surgeons. Vision is typically usable within a day, which is a genuine advantage over surface laser.

The risks specific to ICL

These differ in kind from laser risks, because this is surgery inside the eye rather than on its surface. That is the honest headline: an operation entering the eye carries a small but real risk of intraocular infection, a serious complication treated urgently in hospital, which surface laser does not carry in the same way.

• Vault that is too low. The gap between the implant and the natural lens is called the vault. If it is too small, contact or crowding can accelerate clouding of the natural lens, meaning a cataract earlier than the eye would otherwise have had one.
• Vault that is too high. An implant sitting too far forward can crowd the drainage angle and raise the pressure inside the eye — see eye pressure. Either extreme can require the lens to be exchanged for a different size.
• Endothelial cell loss. The inner cell layer of the cornea does not regenerate. A lens inside the eye is associated with a slow loss of these cells over years, which is why the count is measured before surgery and monitored afterwards, and why a low starting count is a contraindication.
• Halos and glare at night, particularly in eyes with large pupils, since the implant has a defined optical zone like any lens.
• Rotation or repositioning of a toric implant correcting astigmatism, which can require a further short procedure to realign it.

ICL and the eye’s future

An ICL corrects the prescription and nothing else. The natural lens is still there, so it still stiffens with age and clouds eventually; reading glasses are still needed from the mid-forties, and a cataract can still form. When it does, the ICL is removed during the cataract operation and the natural lens replaced in the usual way, described under cataract surgery. Having had an ICL does not complicate that later operation in most eyes.

For the same reason ICL is not a presbyopia treatment. A patient in their fifties is really choosing between correcting the prescription now and dealing with the lens later, or dealing with the lens now — the option set out under refractive lens exchange.

Refractive lens exchange

Refractive lens exchange removes the eye’s clear natural lens and replaces it with an artificial intraocular lens chosen to correct the prescription. It is, in every technical respect, cataract surgery performed before a cataract exists — the same incision, the same ultrasound technique, the same implants, the same recovery. The only differences are the reason for doing it and the fact that the lens being removed is still transparent.

That identity produces one permanent consequence: an eye that has had its lens replaced can never develop a cataract. It has already had the operation.

Why refractive lens exchange is cataract surgery performed earlier

Because the operation is the same, it is not described twice: the technique, the day itself and the recovery are set out under cataract surgery and cataract surgery recovery. What differs is the calculus behind the decision.

In cataract surgery the natural lens has stopped doing its job and there is little to weigh — the operation restores something lost. In refractive lens exchange the lens is still clear, so the operation trades a working part of the eye for a different optical result. That trade is worth making for some patients and clearly not for others, and the difference is almost entirely age and prescription.

Presbyopia correction after 45

Presbyopia correction is the reason most patients over forty-five arrive asking about lens surgery rather than laser. Presbyopia is the loss of the eye’s ability to change focus for near work, and it happens because the natural lens gradually stiffens — not because the cornea has changed. This is why laser is a poor answer to it. Reshaping the cornea can produce excellent distance vision, but the lens inside is still stiffening, and it will keep stiffening. Laser corrects today’s prescription on a structure that is not causing the problem.

There are three broad responses to presbyopia in a refractive context. Reading glasses over corrected distance vision remains the simplest and, for many people, the best. Deliberately leaving one eye slightly short-sighted for near work is the second, and the trade-offs of that arrangement are set out under choosing the lens rather than repeated here. Replacing the lens is the third, and it is the only one that addresses the actual mechanism.

Who refractive lens exchange suits

• Long-sighted patients over forty-five. This is the clearest group. Long sight and presbyopia arrive together and compound each other, glasses are needed for everything rather than only for reading, and the natural lens is often already showing early changes.
• Prescriptions outside the safe range of laser in an eye that is otherwise healthy, where lens surgery achieves what corneal surgery cannot.
• Eyes with early lens changes already visible on examination, where the lens is going to need replacing within a foreseeable period regardless.
• Patients who accept intraocular surgery in order to reduce dependence on glasses for both distance and near, and who understand that this is a likelihood rather than a guarantee.

The choice of implant governs how much near vision is regained, and that decision — monofocal, toric, extended-depth-of-focus or multifocal — is set out under choosing the lens.

Where refractive lens exchange is the wrong operation

Refractive lens exchange in a young, highly short-sighted eye is the clearest example in this field of an operation that can be done and usually should not be. Removing the natural lens from a long, myopic eye raises the lifetime risk of retinal detachment meaningfully, and that eye already carries an elevated risk before anyone touches it. For patients in that position, an implantable lens that leaves the natural lens in place is generally the better answer.

The risks of refractive lens exchange

Two further consequences of refractive lens exchange apply regardless of age.

• Accommodation is removed permanently. Whatever natural focusing ability the eye still had is gone the moment the lens is out. In a patient in their fifties there is little left to lose; in a patient in their early forties there may be a great deal, and they will notice.
• The capsule can cloud afterwards. The membrane the implant sits in commonly thickens in the years after any lens surgery, blurring vision again in a way that is often mistaken for the problem returning. It is not, and it is dealt with under secondary cataract and YAG laser.

What refractive lens exchange cannot promise

Spectacle independence is the usual aim and the common outcome, but it is not a guarantee, and patients who are told otherwise have been misled. Small print in poor light, prolonged close work and night driving are the situations in which glasses most often reappear.

Lenses that provide a range of focus do so by splitting or extending the available light, and the optical cost is glare, halos around lights at night and some reduction in contrast — most noticeable in the first months while the brain adapts, and permanent for a minority who never fully adapt. A patient whose work depends on fine contrast or night driving needs that stated before the decision rather than after it.

Who laser correction suits, and who it does not

A refractive assessment exists to find reasons not to operate. That is not a pessimistic framing — it is the purpose of the tests. Almost anyone can be given a laser treatment; the work lies in identifying the eyes in which it would be a bad idea, before rather than after.

The unit declines laser correction in a defined set of circumstances, and the list is not short. Some refusals are permanent, some mean “not yet”, and some mean “not this procedure, but another one” — a distinction that matters, because being turned down for LASIK is frequently not the same as being turned down for surgery.

Am I a candidate for LASIK?

The question “am I a candidate for LASIK” cannot be answered without measurements, but the criteria themselves are not secret. A straightforward candidate has:

• An adult eye that has finished changing, with a prescription that has been stable for at least a year on documented evidence.
• A prescription within the treatable range for the procedure being considered.
• Enough corneal thickness to leave a safe untreated bed after the correction.
• A regular corneal map, front and back, with no early keratoconus pattern.
• A healthy ocular surface with a stable tear film.
• A healthy retina and optic nerve, and no active inflammation or infection in the eye.
• No pregnancy or breastfeeding at the time of treatment.
• Expectations that match what the procedure does, including a clear understanding of reading vision after forty-five.

Failing one of these does not automatically end the conversation. Failing the corneal map does.

LASIK age limit: why the young are refused and what changes later

There is no single legislated LASIK age limit, but there is a well-established practical one at both ends of adult life.

At the lower end, laser correction is not offered to children or teenagers. A short-sighted eye typically continues to lengthen into the late teens and often into the early twenties, and treating a prescription that is still moving produces a correction that is accurate for a year or two and wrong afterwards, in a cornea that has already spent the tissue needed to fix it. Most surgeons will not treat below eighteen at all, and many prefer to wait past twenty-one unless there is a documented history of stability. Requests for laser in a teenager are declined here on that basis rather than negotiated.

At the upper end there is no maximum age, but the reason for asking the question changes. From the mid-forties the limiting structure is the natural lens, not the cornea, and full distance correction in both eyes reliably produces a need for reading glasses — which is the discussion under refractive lens exchange. Where the lens has already begun to cloud, laser correction is the wrong operation altogether: it would be reshaping the cornea in front of a lens that is going to be removed, and the correction would be undone by cataract surgery when it happens. The appropriate course in that situation is to wait and to treat the lens when the time comes.

Proving that a prescription is stable

Stability is a documentary question as much as a clinical one. Old spectacle prescriptions and previous optometry and contact lens records are the evidence, and several years of them make the assessment far more reliable — which is why records are listed among the things worth carrying under coming from abroad.

Where no history exists, stability is established by measuring twice across an interval, with the contact lens holiday observed properly before both. A prescription that has changed appreciably in the past year is a reason to postpone, not a reason to treat quickly before it moves again.

Corneal thickness and the limit that is not negotiable

The cornea has to keep enough untreated tissue beneath the treatment to hold its shape against the pressure inside the eye for the rest of the patient’s life. In LASIK, the flap does not count towards that structural reserve, so both the flap and the tissue removed come out of the same budget.

The widely used minimum is a residual stromal bed of around 250 to 300 microns, and most surgeons work conservatively above the lower end of that range. Surgeons also consider the proportion of the whole cornea being altered, not only the absolute figure left behind, because a given depth of treatment means something different in a thin cornea than in a thick one.

The practical consequence is simple and is stated plainly to patients who do not want to hear it: where a prescription will not fit inside LASIK’s thickness budget, the answer is surface laser, or an implantable lens, or no surgery. The unit does not thin a cornea past the accepted margin in order to make a prescription fit the procedure a patient came in asking for.

Keratoconus screening, and the map that stops everything

The most important single result in the whole work-up is the corneal tomography. Its job is to detect eyes with an early, subclinical form of keratoconus — corneas that look normal to the patient, correct to good vision with glasses, and are nonetheless already biomechanically weak.

Removing tissue from such a cornea can trigger progressive steepening and thinning afterwards, described under the risks of laser correction. It is uncommon, it is serious, and it is largely preventable by refusing to treat the eyes that show the pattern. The features that raise suspicion include asymmetry between the two eyes, an irregular or displaced steep zone, thinning that is off-centre, abnormalities of the back surface, a family history of keratoconus, and habitual vigorous eye rubbing.

A suspicious map is a stop. It remains a stop when the patient has already been offered surgery elsewhere, when they have travelled a long way, and when their vision with glasses is excellent. Where progression is present, the relevant treatment is corneal cross-linking to stabilise the cornea — a different operation with a different purpose, and not a stepping stone to laser correction.

Dry eye, checked before rather than after

A tear film that is already unstable before surgery is the best predictor of significant symptoms afterwards, because every corneal procedure disrupts the nerves that drive tear production. Screening the surface first is therefore not a box-ticking exercise: it changes the recommendation.

Where dry eye is present but treatable, the sequence is to treat the surface first and re-measure, since a poor tear film also degrades the accuracy of the measurements the whole plan is built on. Where it is significant and persistent, the options shift towards an implantable lens, which does not disturb the corneal nerves across the optical zone. Where it stems from an underlying condition affecting the whole ocular surface, laser correction is generally declined. The condition itself is covered under dry eye.

The other reasons the answer is no

• Glaucoma, or optic nerve damage under surveillance. Beyond the disease itself, corneal thinning permanently distorts how pressure is measured afterwards, which complicates monitoring for life — see eye pressure.
• Diabetic eye disease that is active or unstable. Refraction shifts with blood glucose, and the priority is the retina, not the prescription — see diabetic eye disease.
• Autoimmune and connective tissue disease affecting the ocular surface or healing, which makes the response to treatment unpredictable.
• A history of herpes simplex infection of the cornea, which laser treatment can reactivate.
• Active infection, inflammation inside the eye, or significant corneal scarring.
• Pregnancy and breastfeeding, during which the prescription itself can shift; treatment is postponed rather than refused.
• Very large pupils combined with a high correction, which raises the likelihood of the night-vision effects described under the risks of laser correction. This is a discussion rather than an automatic refusal.
• Expectations that cannot be met. A patient who wants perfect unaided vision at every distance for the rest of their life is asking for something no refractive procedure delivers, and proceeding on that basis produces an unhappy result from a technically successful operation.

When the answer is not laser, but something else

A refusal is frequently a redirection. A cornea too thin for LASIK may be entirely suitable for surface laser. An eye beyond the range of any laser is often a good candidate for an implantable lens. A patient over fifty whose lens is already changing is heading for refractive lens exchange. And for some people the correct outcome of a thorough assessment is that their eyes are best left alone and their glasses are the right answer — a legitimate result of the process, not a failure of it.

The risks of laser correction, stated plainly

Laser vision correction is well established and most people who have it are pleased with the result. That is true, and it is also where most accounts stop — which leaves patients unprepared for effects that are common, temporary and alarming if nobody mentioned them, and for a small number of outcomes that are permanent.

They fall into three groups: the effects almost everyone gets and almost everyone loses; the effects that persist in a minority and change the quality of vision rather than its sharpness; and the rare complications that the screening described under candidacy exists to prevent.

LASIK side effects in the first weeks

The common LASIK side effects are part of normal healing rather than signs that something has gone wrong:

• Fluctuating vision. Sharpness varies through the day and between days for several weeks, often clearer in the morning or after rest.
• Grittiness and a foreign-body sensation, worst in the first days and typically settling over weeks.
• Watering and light sensitivity, most marked in the first day or two.
• A red patch on the white of the eye, from the suction ring. It looks dramatic, causes no harm, and clears like any bruise.
• Halos and starbursts around lights at night, most pronounced early and improving in most people.
• Reading strain, especially in patients approaching presbyopia, whose near vision may have been quietly propped up by their short sight beforehand.

Surface laser produces a different early picture: several days of genuine discomfort while the surface heals under a bandage contact lens, and blurred vision that clears slowly rather than overnight. That is expected, and it is the price of avoiding a flap.

Dry eye after LASIK

Dry eye after LASIK is the most common lasting complaint, and the mechanism explains why. The corneal nerves that sense the surface and signal for tear production run through the tissue that a flap cuts across and a laser reshapes. Interrupting them reduces both tear production and the blink reflex that spreads the tear film, so the surface dries and the vision fluctuates with it.

The pattern is fairly consistent: symptoms are at their worst in the first weeks to months and improve as the nerves regenerate, and most people return to something close to their baseline. A minority do not, and continue to need ongoing management of a dry ocular surface. Where dry eye already existed before surgery, the odds of persistence are higher — which is the whole reason it is screened for beforehand.

The three procedures differ here. SMILE cuts fewer nerves because the incision is small, and tends to produce less early dryness. Surface laser disrupts the nerve plexus too but in a different distribution, with symptoms that often build later and settle differently. No corneal procedure avoids the phenomenon entirely; only an intraocular option does. Treatment of the condition itself is covered under dry eye, and the specific medication used in any individual case is a decision for the treating ophthalmologist.

Night glare, halos and starbursts

Night-vision disturbance is the effect patients most regret when it persists, and it is worth understanding rather than dismissing.

The laser reshapes a defined optical zone, with a blend zone at its edge. In daylight the pupil is small and sits well inside the treated area. In darkness the pupil dilates, and if it opens beyond the treated zone, light entering through the periphery passes through cornea with a different curvature and does not focus with the rest. The result is a halo or a starburst around headlights and street lamps. Stronger corrections, which need deeper and relatively narrower treatments, and larger pupils both increase it.

Modern lasers use wider optical zones and smoother transitions, and this has reduced the problem substantially compared with early treatments — but it has not eliminated it. Symptoms usually improve over the first months as healing completes and the brain adapts. For a small number of people the change is permanent, it is a genuine reduction in the quality of vision at night, and a further laser treatment cannot reliably correct it. That weighs most heavily for people who drive at night for a living, and it belongs in the decision rather than in the recovery.

Undercorrection, overcorrection and enhancement

The laser delivers a precise treatment, but the eye’s healing response varies from person to person and the final refraction reflects both. Some eyes end slightly under-corrected, some slightly over-corrected, and some drift back towards the original prescription over the following years — regression, which is more likely after high corrections and after treatment for long sight.

A second treatment, called an enhancement, can often address a residual prescription. It is not automatic, and three conditions have to be met: the refraction must be stable again, there must be enough corneal thickness left within the limits set out under candidacy, and the map must still be regular. Some eyes fail one of those tests, and for them the residual prescription is corrected with glasses or contact lenses instead.

The route matters too. Lifting an old LASIK flap years later is possible but carries a risk of epithelial cells growing in under the flap edge, so surface ablation over the flap is often preferred at that stage. After SMILE there is no flap to lift and the enhancement is done as a surface treatment or by creating a flap then. And because enhancement policies differ between clinics, the terms under which one would be provided are part of what a laser eye surgery price contains.

Flap complications after LASIK

These are specific to LASIK and are the price of the flap that makes it comfortable:

• An incomplete or irregular flap. Uncommon, and the correct response is to abandon the treatment for that day and let the cornea heal before reconsidering. A postponed procedure is a good outcome in this situation, not a failed one.
• Flap wrinkles. Fine striae in the replaced flap can blur vision and are treated by lifting and repositioning it.
• Epithelial ingrowth. Surface cells migrating under the flap edge, which is monitored if minor and cleared surgically if it progresses towards the visual axis.
• Diffuse lamellar keratitis. An inflammatory reaction in the interface in the first days, treated intensively with anti-inflammatory drops under close review, and occasionally by lifting and washing out the interface.
• Late flap displacement. A LASIK flap never regains the full tensile strength of uncut cornea. A sufficiently hard blow to the eye can shift it years after surgery. A displaced flap is repaired urgently in hospital, and the possibility is the reason surface laser is preferred for people whose sport or occupation involves impact.

Corneal ectasia: the rare one that shapes the whole assessment

Ectasia is progressive steepening and thinning of the cornea after refractive surgery, in which the treated cornea gradually bulges under the eye’s own internal pressure. Short sight and irregular astigmatism return, vision becomes distorted rather than merely blurred, and glasses stop correcting it well.

It is rare. It is also the most serious complication of laser correction, because it is progressive and it is not reversed by further laser. Management follows the same path as advanced keratoconus: rigid or scleral contact lenses to restore a regular optical surface, corneal cross-linking to halt further change, and in severe cases corneal transplant.

Its risk factors are, almost exactly, the criteria the screening is built around: an abnormal or borderline corneal map, insufficient residual thickness, high correction in a thin cornea, and young age. This is the reason a suspicious tomography ends the discussion, and the reason a thorough assessment is not an upsell.

Haze, infection and inflammation

Haze is specific to surface laser — a fine scarring response in the healing surface that reduces contrast and can blur vision. It is more likely after high corrections and with strong ultraviolet exposure during the healing period, and it is mitigated in selected cases by applying mitomycin-C to the treated surface during the operation. Most haze that appears fades over months; a small amount persists.

Infection after any corneal procedure is uncommon and serious. Surface laser is most vulnerable during the days when the epithelium has not yet closed and a bandage contact lens is in place. Infection of the cornea is treated urgently in hospital and can leave scarring even when it is controlled. Sterile inflammation, which is not infection, can produce similar early redness and blurring and is distinguished by examination rather than by symptoms.

What laser correction leaves behind for later care

The limits of what the correction fixes are set out under laser vision correction. Two consequences are different in kind, because they outlast the recovery and change how reliably the eye can be assessed for the rest of the patient’s life.

• Eye pressure reads falsely low afterwards. A thinned cornea makes standard pressure measurement under-read, sometimes substantially, which can mask developing glaucoma for years.
• Lens power calculation becomes harder. Previous laser treatment makes the implant power calculation for later cataract surgery less straightforward.

For both reasons the pre-operative corneal thickness, pressure and biometry figures stay clinically relevant for decades, which is why they are recorded and given to the patient at the end of treatment. Excellent unaided vision can also create a false impression that the eye has become an ordinary eye. A treated short-sighted eye is still a long eye, and its retinal surveillance needs are exactly what they were.

None of this argues against laser correction. It argues for making the decision with the full picture: a procedure that reliably removes a dependence on glasses for distance, that carries a small set of uncommon but real risks, that leaves the rest of the eye exactly as it found it, and that is worth declining in the eyes where the assessment says so.

Laser eye surgery Turkey: what to check before travelling

Turkey is one of the largest destinations for laser eye surgery, and searches for laser eye surgery Turkey — along with eye surgery Turkey and laser eye surgery Istanbul — are among the most common medical travel queries in this field. What follows is not a case for travelling. It is a description of what separates a well-run pathway from a badly run one, because in refractive surgery the difference is almost never the laser.

The treatment itself is the most standardised part. The platforms are the same machines sold worldwide, the procedure takes minutes, and an experienced surgeon performs it much the same way in Istanbul, London or Chicago. What differs is the screening that decides whether you should have it at all, and what happens in the weeks afterwards.

That is the whole argument in this specialty, and it is worth stating bluntly: refractive surgery is a screening problem, not a laser problem. The corneal thickness, the topography that reveals a cornea beginning to change shape, the tear film, the pupil size, the stability of the prescription over time — these decide whether treatment is safe, which procedure suits the eye, and whether the result will hold. The conditions that must be excluded are set out under candidacy, and the outcomes that screening exists to prevent are described under risks. None of that can be established from a prescription emailed in advance.

The practical consequence is a single test that separates providers anywhere in the world: could this pathway have ended in a refusal? A meaningful proportion of people who want laser correction are not suitable for it, and a unit that finds that out reliably is doing the most valuable part of its job. A pathway that confirms suitability before you have been examined has not assessed you; it has quoted you.

LASIK Turkey and laser eye surgery abroad: what changes and what does not

Searches for LASIK Turkey, LASIK eye surgery Turkey and laser eye surgery abroad generally come down to the same three practical questions.

• Can the assessment and the treatment happen in one visit? For laser vision correction, usually yes — but not on the same day. The full examination requires the eye to be measured accurately, and contact lenses have to have been out long enough beforehand for the cornea to return to its own shape; soft lenses need days, rigid lenses considerably longer. Arriving with lenses worn until the flight is the commonest reason a trip has to be rearranged.
• Who sees you in the first days? The early checks after laser correction are not formalities. They confirm the flap is seated after LASIK, that the surface is healing after PRK, and that pressure and inflammation are behaving. Those visits happen where the surgery happened, which is the real constraint on when a return flight can be booked.
• What happens if the result needs adjusting? A proportion of eyes need a retreatment, more often in higher prescriptions. Whether an enhancement is included, for how long, and whether it requires a further trip is a written question to ask before booking, and it is one of the clearest differences between a quotation and a package.

What does not change with distance is the clinical reasoning: which procedure suits a cornea, when surface ablation is preferred over a flap, and when the right answer is a lens rather than a laser. Those are set out under LASIK, PRK and SMILE compared and implantable lenses. The general sequencing of an international visit — including the treatments that are programmes rather than single events, and the one restriction after retinal surgery that is absolute — is covered under coming from abroad rather than repeated here.

Laser eye surgery Turkey cost: what a complete quotation covers

Cost is the dominant reason people search laser eye surgery Turkey cost and laser eye surgery Turkey price, and it is a reasonable reason: the difference against private treatment in the United Kingdom, Ireland or the United States is real, and it is largely explained by what it costs to run a clinic rather than by any difference in the equipment. This page does not publish a figure, because a number without a defined scope is not a price — the same reasoning applies to cataract and refractive quotations generally.

What is worth comparing is scope. A complete quotation covers the full preoperative examination including corneal topography and thickness measurement; the treatment itself, with the procedure named rather than described as “laser”; the postoperative medication; the early follow-up visits; the position on retreatment, with a stated period; and what happens if the examination concludes that you are not a candidate, since that outcome has to be possible for the assessment to mean anything.

Two things are commonly missing from the cheapest headline. The first is the procedure: LASIK, PRK and SMILE are not interchangeable and are not priced the same, so a quotation that does not name one is quoting for a category. The second is the retreatment position, which is the item most likely to matter and the one most often left to be discussed later.

Glaucoma

Glaucoma is damage to the optic nerve — the cable of roughly a million fibres that carries everything the eye sees to the brain — usually, but not always, driven by the pressure inside the eye being too high for that particular nerve to tolerate. The fibres die from the outside of the field inwards. They do not grow back. That single fact shapes everything else: glaucoma is a disease of protection rather than repair, and every decision in it is made to defend the vision a person still has.

It is also the most misunderstood eye disease there is, for one reason: it does not hurt, and for years it does not look like anything is wrong.

What glaucoma actually is

The eye is a pressurised sphere. Clear fluid — aqueous humour, not tears — is made continuously behind the iris, flows forward through the pupil, and drains out through a ring of spongy tissue in the angle where the iris meets the cornea. That balance between production and drainage sets the pressure inside the eye. When drainage slows and production does not, the pressure rises.

The optic nerve leaves the back of the eye through a small opening in the sclera. Raised pressure squeezes the fibres where they turn to pass through it, and blood supply to the nerve head matters as much as the mechanical squeeze — which is why blood pressure, sleep apnoea and vascular disease all appear in the glaucoma conversation. Fibres die a few at a time, and the optic disc slowly hollows out as they go. That hollow — the cup — is what an ophthalmologist means when they say a disc looks suspicious.

The damage is therefore measurable before it is noticeable, which is the entire basis of the scans covered under the tests.

Glaucoma symptoms, and why they arrive so late

The honest answer to what glaucoma symptoms feel like, in the common form, is that there are none for a long time. Chronic open-angle glaucoma is painless, produces no redness, no discharge and no blurring, and it takes vision in a place and in an order the brain is unusually good at hiding. Three mechanisms conspire to hide it:

• It starts in the periphery, not the centre. Reading vision, faces and the letters on a test chart stay normal until late. Someone can have substantial nerve damage and still read the bottom line.
• Two eyes overlap. A blind patch in one eye sits inside the seeing field of the other. Until both eyes are affected in the same place, nothing looks missing.
• The brain fills in. The visual system does not render a black hole where data is absent; it paints in the surroundings. People do not see a gap. They see a complete world with things quietly missing from it.

When symptoms do appear in chronic glaucoma, they are usually described like this:

• Bumping into door frames, catching the wing mirror, missing a step or a kerb on one side.
• Difficulty in dim light and a slow, uncomfortable adjustment coming indoors from bright sun.
• Losing the thread when reading — the next line is harder to find than it used to be.
• Needing more light for everything, and finding night driving unpleasant rather than impossible.
• A vague sense that vision is worse, with a normal glasses test to contradict it.

None of these is specific to glaucoma; every one of them has ordinary explanations too. The point is the opposite of a checklist. Because reliable symptoms arrive only after significant damage, glaucoma in the common form is found by examination rather than by complaint, and a large share of it is found by accident, in people who came in for new reading glasses or as part of a routine health check-up and had no idea anything was wrong.

Open-angle glaucoma, the common and quiet form

In primary open-angle glaucoma the drainage angle is anatomically open — a mirrored lens can be placed on the eye and the drainage ring is plainly visible — but the tissue itself has become resistant, the way a filter clogs without changing shape. Fluid leaves too slowly, pressure creeps up, and the nerve is damaged over years to decades. This form accounts for most glaucoma in most populations, and it is usually present in both eyes but rarely at the same rate — one eye typically runs ahead of the other, which is another reason the better eye masks the worse.

Angle-closure glaucoma, the form that can announce itself

In angle closure the geometry is the problem rather than the filter. In a shorter eye, with a crowded front chamber, the iris can press forward against the drainage ring and physically block it. That happens in two very different ways.

Chronic angle closure behaves like the open-angle form — silent, progressive, found on examination — except that the angle is narrow or partly closed when it is inspected.

Acute angle closure is the exception to everything else in glaucoma, because it is loud. The angle shuts, the pressure rises steeply over hours, and the eye becomes red and painful. Vision blurs, lights acquire coloured haloes, and the headache and nausea can be severe enough that the eye is not the first thing anyone suspects — attacks have been treated as migraine and as a stomach upset. It is an ophthalmic emergency and is treated in hospital: medication first to bring the pressure down, then a laser opening in the iris, described under laser and surgery for glaucoma.

Being told at a routine examination that the angles look narrow, before anything has happened, is a useful piece of information and is the reason gonioscopy exists.

Normal-tension glaucoma and secondary glaucoma

A significant minority of people develop classic glaucomatous damage with pressures that never leave the statistical normal range. This is normal-tension glaucoma, and it is real rather than a measurement error. The nerve in these eyes appears unusually vulnerable — poor perfusion, low blood pressure at night, migraine and sleep apnoea all feature more often than chance. It is still treated by lowering pressure, because that is the only lever anyone has, and the target is simply set below the starting point. What a pressure number can and cannot rule out is covered under eye pressure.

Glaucoma can also be secondary to something else in the eye: pigment shed from the iris clogging the drainage ring; pseudoexfoliation, a flaky deposit associated with high, unstable pressures; inflammation from uveitis; long-term steroid treatment in people who respond with a pressure rise; a previous injury; or advanced diabetic eye disease and vein blockages that grow new vessels across the angle. Secondary glaucoma is treated as two problems at once, and the cause usually decides the outcome.

Glaucoma in babies and young children is a separate disease with different surgery and a different urgency, and it is covered under children’s eyes.

Who is at higher risk

Risk is not a diagnosis, and most people with these features never develop glaucoma. They are listed because they change how closely an eye is watched:

• Age. Prevalence rises steadily with each decade.
• Family history. A parent or sibling with glaucoma is one of the strongest risk factors known, and the one most often unknown, because the relative was told they had “pressure” and never used the word.
• Ancestry. Open-angle glaucoma is more common, starts earlier and behaves more aggressively in people of African and Caribbean descent; angle closure is more common in East Asian populations.
• Higher pressure to begin with — the strongest modifiable factor, and the only one treatment can act on.
• A thin cornea, which is both a measurement problem and an independent risk factor in its own right.
• High short-sightedness for open-angle glaucoma; high long-sightedness for angle closure.
• Steroid use in any form, in the subset of people whose pressure responds to it, and previous eye injury or surgery, sometimes decades earlier.
• Obstructive sleep apnoea, low nocturnal blood pressure and vascular disease, particularly where the pressure looks unremarkable.

Because the disease is silent, the interval between examinations is set by risk and by what the previous tests showed, not by whether anything feels wrong.

Eye pressure, and what the number means

Eye pressure — intraocular pressure, written as a number in millimetres of mercury, mmHg — is the internal pressure of the eyeball, produced by the balance between fluid made inside the eye and fluid draining out of it. It is the one number in glaucoma that patients remember, quote and worry about, and it is routinely over-read. A pressure number is a risk factor measured on one morning. It is not a diagnosis, not a verdict and not a score.

Everything else in glaucoma refers back to this number, so it is worth being exact about what it does and does not tell anyone.

The normal range, and what it is not

The conventionally quoted normal range is about 10 to 21 mmHg. That range is a statistical description of a healthy population, not a safety boundary. It was derived by measuring a lot of eyes and drawing lines around the middle of the distribution, which has two consequences that matter enormously and are almost never explained.

A pressure of 22 does not mean glaucoma. Plenty of people sit above the range for life with a healthy optic nerve and a full field of vision — pressure without damage, which is called ocular hypertension. It is watched rather than automatically treated, and the decision to treat depends on the whole risk picture rather than on crossing 21.

A pressure of 15 does not mean safety. If a particular optic nerve is being damaged at 15, then 15 is too high for that eye, whatever the population average says. This is the entire concept behind normal-tension glaucoma, and it is why a nerve that is deteriorating is treated even when the number looks reassuring.

Pressure also moves. It varies through the day in everyone, typically higher in the early morning, and the size of that swing is itself meaningful — an eye that ranges widely is under more strain than a steady one at the same average. A single clinic reading catches one point on that curve, usually in the middle of the day, which is precisely when many eyes read at their lowest. Repeat measurements at different times of day exist for this reason, and a set of readings is worth more than any one of them.

How eye pressure is measured

Three methods are in routine use, and they do not always agree with one another.

Goldmann applanation tonometry is the reference standard. A drop of anaesthetic and a drop of orange dye go in, and a small flat-tipped probe on the slit lamp touches the front of the cornea for a second or two while the examiner turns a dial. It is painless — the anaesthetic works before the probe arrives — and the odd part is not the sensation but the blue light and having to hold still while something approaches the eye. Blinking does not damage anything; it just means starting again.

Non-contact tonometry, the air puff, fires a brief pulse of air at the cornea and measures how much it flattens. Nothing touches the eye and no anaesthetic is needed. It is quick and well suited to screening, it startles almost everyone, and it is less precise than applanation, particularly at higher pressures. An unexpected air-puff reading is normally confirmed by contact tonometry rather than acted on.

Rebound tonometry bounces a tiny lightweight probe off the cornea. No anaesthetic, minimal sensation, and it works where the other two are difficult — in children, and in a scarred or irregular cornea.

Readings are usually taken in both eyes and compared. A consistent difference between the two eyes is itself a finding, because the same person’s eyes usually run close together.

Corneal thickness changes the reading

Applanation tonometry works by flattening the cornea, so the cornea’s own stiffness is part of what is being measured. A thick cornea resists flattening and the machine reads high; a thin cornea gives way easily and the machine reads low. The pressure inside the eye has not changed. Only the measurement has.

This matters in two directions. Someone with a thick cornea can be treated for years for a pressure they never had. Someone with a thin cornea can be reassured by a number that understates the true figure — and a thin cornea is also an independent risk factor for progression, so those eyes carry a double disadvantage. Corneal thickness is measured by pachymetry, described under the tests, and it is measured once and kept, because it does not change on its own. The exception is an eye that has had laser vision correction: the cornea has been deliberately thinned, applanation readings run low afterwards, and the pre-laser measurements become permanently relevant, as noted under the risks of laser correction.

Why a normal pressure does not exclude glaucoma

This is the single most consequential misunderstanding in the subject. A patient is told their pressure is fine, hears it as “your eyes are fine”, and does not return for years.

Pressure is one of four things a glaucoma assessment looks at. The other three are the appearance of the optic disc, the thickness of the nerve fibre layer on an OCT scan, and the visual field. Glaucoma is diagnosed from the pattern across all four and, more often, from how that pattern changes over time. A normal pressure alongside a hollowed disc, thinning nerve fibres and a matching field defect is glaucoma with a normal pressure — a well-described condition, not a contradiction.

The reverse holds as well. A high pressure with a healthy disc, a normal OCT and a full field is ocular hypertension, which is monitored. Neither number nor picture rules the other out. What settles it is the combination, watched over time.

Treating glaucoma

Glaucoma treatment has exactly one mechanism available to it: lowering the pressure inside the eye. Drops lower it, laser lowers it, surgery lowers it. Nothing in current practice regenerates optic nerve fibres, improves the field of vision or restores what has already gone. Treatment protects the vision that remains, and when it works, the reward is that nothing happens — for decades.

That is an unsatisfying deal for a patient who feels perfectly well, and it explains most of what goes wrong in glaucoma care.

What glaucoma treatment is trying to do

Lowering pressure slows the rate at which nerve fibres are lost. It does not stop the clock for everyone, and it does not reverse anything. The practical aim is to keep the field of vision the person needs for the life they have left to live — which is why age matters. Slowly progressing damage in an eye of eighty carries a different weight from the same damage at forty-five, and treatment intensity is calibrated to that, not to the number alone.

Target pressure, and why it is personal

Every treated eye is given a target pressure: the level judged low enough to stop that particular nerve deteriorating further. It is set from the pressure the damage occurred at, how advanced the damage is, how fast it has moved, corneal thickness, age and family history. Two people with identical readings can be given different targets, and the same eye can have its target lowered later if it keeps changing.

A target is a working hypothesis, not a promise. It is tested by watching the disc, the OCT and the field — and if the eye continues to deteriorate at the agreed target, the target was wrong and gets lowered. That is the logic that moves someone from drops to laser, and from laser to surgery.

Glaucoma eye drops

Glaucoma eye drops are the usual first treatment, and they work in one of two ways: reducing how much fluid the eye makes, or increasing how much drains out. The main groups are prostaglandin analogues, which improve outflow and are commonly used first because they are effective once daily; beta-blockers, which reduce production; alpha agonists and carbonic anhydrase inhibitors, which do a bit of both; and cholinergic agents, used more selectively. Combination bottles put two agents in one drop to reduce the number of instillations.

Which agent, which combination and what schedule is a prescribing decision made by the ophthalmologist who knows the eye — no drop is started, stopped, swapped or spaced differently on the strength of general information, and that includes drops that seem to be doing nothing, because in glaucoma nothing is what success feels like.

What is fair to describe is the experience. Drops are for life in most cases. Prostaglandins commonly darken and lengthen the lashes, can darken the iris permanently in hazel eyes and can hollow the eyelid slightly — cosmetic effects usually only noticed when one eye is treated and the other is not. Preservatives, benzalkonium chloride in particular, irritate the ocular surface over years and are a genuine cause of dry eye in long-treated patients, which is why preservative-free versions exist. Drops are also absorbed into the bloodstream through the tear duct, so a full list of medicines and conditions — asthma and slow heart rhythms in particular — belongs in the eye assessment, since the class that suits one person’s eye may not suit their chest.

The part nobody discusses: taking drops for decades

Adherence is the largest single problem in glaucoma, larger than any difference between agents. A substantial proportion of prescribed drops are not taken as intended, and technique is frequently wrong even when intention is perfect. The drop misses the eye. It lands on the lashes. Two go in where one was meant to, and the bottle runs out early. Nobody mentions any of this at the review, and the treatment is judged to have failed.

The reasons are ordinary. The disease produces no symptoms, so nothing reminds anyone. Arthritic hands cannot squeeze a small bottle. Travel disrupts routine. Drops sting. When treatment appears not to be working, the useful first question is whether the drops are reaching the eye at all — and an honest answer to it changes the plan more often than a new prescription would. It is also why laser has moved earlier in the sequence for many patients: a laser that works does not have to be remembered.

Oral tablets exist as well. Carbonic anhydrase inhibitors taken by mouth lower pressure effectively but are used in short bursts — around surgery, during an acute rise, or as a bridge while a longer-term plan is arranged — because the side effects at systemic dose are poorly tolerated: tingling in the fingers and lips, taste changes, tiredness, stomach upset, and effects on kidneys and blood chemistry that require monitoring.

How treatment is monitored over time

Monitoring is the treatment, in the sense that nothing can be judged without it. A stable glaucoma patient is seen periodically for pressure, the optic disc, an OCT scan and a visual field, at an interval set by how advanced and how fast-moving the disease is.

Two principles govern it, and both belong to the tests rather than to the treatment: sequential results only mean something when they are produced the same way every time, and a first visual field is routinely the worst one a person ever does. Both are set out under the tests, and what each one answers.

Glaucoma follow-up is lifelong and local. Acıbadem International can assess an eye, establish a diagnosis, perform laser treatment and operate, but a person who lives elsewhere will be monitored where they live for the rest of their life, and that is the correct arrangement rather than a shortfall. What makes it work is the record: printed fields, OCT reports with the machine named, corneal thickness, pressures with the method used, and the operation note. Practical sequencing for people travelling for treatment is covered under coming from abroad.

What treatment cannot do

Stated plainly, because it is regularly implied otherwise. Treatment does not restore lost visual field. It does not improve the vision on the chart. It does not cure the disease — pressure-lowering has to continue, in one form or another, for life. And it does not guarantee stability: a proportion of eyes progress despite pressures that reach every target set for them, and where that happens the honest position is to say so rather than to keep promising that the next agent will settle it.

Where damage is already advanced, the aim narrows to preserving useful central vision and the mobility that depends on the remaining field, and low-vision assessment becomes part of the plan rather than an admission of defeat.

Laser and surgery for glaucoma

Glaucoma surgery covers everything from a few minutes of laser in a clinic chair to a formal operation that builds a new drainage route out of the eye. All of it does the same thing as the drops: it lowers pressure. None of it improves sight. Understanding that one sentence prevents the commonest disappointment in the field — an operation that is a technical success and a personal let-down, because the patient expected to see better afterwards.

When glaucoma surgery is considered

Glaucoma surgery enters the conversation when pressure-lowering by other means is not achieving what the eye needs. In practice there are four triggers: the target pressure is not being reached; the target is being reached and the eye is deteriorating anyway; the drops are not tolerated or cannot realistically be taken over a lifetime; or the damage is advanced enough at the outset that a low, stable pressure is needed quickly rather than gradually.

Angle closure is the exception, treated with laser as a matter of course, because the problem is a blocked route rather than a slow filter. And a patient whose pressure is controlled, whose fields are stable and whose scans have not moved in years does not need an operation, however far they have travelled — a unit that offers one anyway is selling a procedure, not treating a disease.

Selective laser trabeculoplasty (SLT)

Selective laser trabeculoplasty is an outpatient laser treatment aimed at the drainage ring itself, to make it work better. It uses very short, low-energy pulses that are absorbed selectively by pigmented cells in the drainage tissue, triggering a biological remodelling response without burning or scarring. Because it does not scar, it can usually be repeated.

The appointment is short. An anaesthetic drop goes in, a mirrored contact lens is held against the eye, and a series of laser applications is delivered around the drainage angle. People describe seeing flashes of light and feeling a faint tapping or nothing at all. Vision is blurred afterwards from the lens gel, and the eye may ache mildly and look pink for a day. Pressure is checked afterwards and again in the following weeks, because it can rise briefly before it falls.

Two honest limits. It does not work in every eye, and it is not permanent — the effect wears off over years, at which point it can often be repeated or another route taken.

Laser for angle closure

Laser peripheral iridotomy makes a tiny full-thickness opening near the edge of the iris, giving fluid a direct route to the front chamber and letting the iris fall back off the drainage angle. It is done in a clinic chair with an anaesthetic drop and a contact lens, takes minutes, and is used both to treat an acute attack and to protect an eye whose angles have been found dangerously narrow before anything has happened. The other eye is usually treated as well.

In some angle-closure eyes the most effective pressure-lowering step is removing the lens, because the lens itself is crowding the front of the eye — that operation is cataract surgery, done for a pressure reason rather than a clouding one.

Minimally invasive glaucoma surgery (MIGS)

Minimally invasive glaucoma surgery is a group of small devices and techniques that improve the eye’s own drainage through a tiny incision, with far less disturbance than traditional filtering surgery. Some place a microscopic stent through the drainage ring into the collector channels behind it; some open or strip a section of that ring; some create a pathway to the space beneath the conjunctiva from inside the eye.

Most are performed at the same sitting as cataract surgery, which is the natural pairing: the eye is already open, recovery is dominated by the cataract part, and the combination often reduces the drop burden. The honest characterisation is modest but real. MIGS lowers pressure less than trabeculectomy does, and it aims at mild to moderate disease and at reducing dependence on drops rather than at rescuing an eye in trouble; its advantage is the risk profile, since the serious complications of filtering surgery are largely avoided. An eye with advanced damage that needs a low single-figure pressure is not a MIGS candidate, and being told so is the system working correctly.

Trabeculectomy, the long-standing benchmark

Trabeculectomy creates a new drainage channel: a guarded flap in the sclera under the upper eyelid, through which fluid seeps out of the eye into a low blister of tissue called a bleb, from where it is absorbed. It has been done for decades, it lowers pressure further and more reliably than anything less invasive, and it remains the comparison every newer procedure is measured against.

It is also the most demanding on both sides. It is performed under local anaesthesia (local anesthesia) in most cases and takes under an hour; the aftermath is the difficult part. Vision is blurred for weeks and is often worse than before the operation for a while. Drops continue afterwards, but different ones — steroid and antibiotic, tapered over an extended course to control healing. The follow-up is intensive, with frequent visits in the first months to adjust the flow: sutures may be released or cut with a laser, and massage or injections used to keep the bleb working. Anti-scarring medication is applied during surgery because the body’s attempt to heal the channel closed is the main reason these operations fail.

The specific risks are stated plainly. Pressure can fall too low, causing blurred vision and, in some eyes, fluid collecting under the retina or choroid. Cataract formation is accelerated, so a person with a clear lens should expect that cataract surgery may follow sooner than it otherwise would. The bleb can leak or, rarely, become infected — a serious event that can occur years afterwards, and the reason a red, sore, sticky eye in someone with a bleb is looked at rather than treated as conjunctivitis. Vision loss directly attributable to the surgery is uncommon but is not zero, and is more likely in eyes that were already advanced.

Drainage tubes and cyclodiode

A glaucoma drainage device is a small silicone tube passed into the front chamber, connected to a plate stitched to the wall of the eye, where fluid collects and is absorbed. Tubes are chosen where a trabeculectomy is likely to fail or has already failed: eyes with extensive previous surgery, scarred conjunctiva, inflammatory glaucoma, or new vessels across the angle. The pressure course is often bumpy in the first months — some devices are deliberately tied off at first and open weeks later, so an early pressure that looks unchanged is expected rather than a failure. Double vision from the plate disturbing an eye muscle, tube exposure, and corneal cell loss are the recognised problems.

A different approach abandons drainage altogether. Cyclophotocoagulation uses laser on the ciliary body — the tissue that makes the fluid — so the eye produces less of it. Traditional transscleral cyclodiode has historically been reserved for eyes with poor visual potential or painful high pressure, because it is inflammatory and its effect is hard to titrate; gentler micropulse versions and endoscopic delivery during other surgery have widened its use. Over-treatment, dropping the pressure permanently too far, is the risk that defines how cautiously it is dosed.

What recovery from glaucoma surgery involves

Laser treatments are effectively same-day events, and ordinary activity resumes almost immediately. MIGS combined with cataract surgery follows the cataract timetable set out under cataract surgery recovery, with a slightly higher chance of a red eye and a small bleed in the front chamber that clears over days.

Filtering surgery and tubes are different in kind. The eye is sore rather than painful, vision blurs and fluctuates for weeks, and the shape of the eye can change enough to alter the glasses prescription, so new glasses wait until things have settled. Heavy lifting, straining, swimming and eye rubbing are restricted for a period. The cornea can also hold water for a time after any long procedure inside the eye — corneal oedema (corneal edema) — leaving vision hazy until it clears. The commonest surprise is how much follow-up is involved: the operation takes under an hour and the management of it takes months.

The trade-off nobody should skip

Every glaucoma operation trades a certain, immediate risk against an uncertain, future benefit. The risk is to an eye that currently sees; the benefit is vision that will not be lost in twenty years’ time. That calculation looks entirely different at forty-five with advanced damage than at eighty-five with mild damage and a controlled pressure, which is why two eyes with identical numbers are correctly offered different plans. An eye that is stable is left alone — doing nothing, deliberately and with a follow-up interval attached, is a legitimate outcome of a glaucoma assessment.

The tests, and what each one answers

An eye examination is a sequence of measurements, and each one answers a specific question. Knowing which question belongs to which machine makes an appointment far less bewildering. Not every test is done at every visit; what follows is the full toolkit, not a checklist.

The examination itself: vision, refraction and the slit lamp

Visual acuity is the letters on the chart, measured one eye at a time, with and without glasses. It answers one narrow question — how much fine detail the centre of the retina resolves — and it is the least sensitive test in ophthalmology for everything except a problem in the very middle of the macula. Full marks on the chart are entirely compatible with substantial glaucoma damage. Refraction then measures the lens power that gives the best vision, separating a blur that glasses can fix from a blur that they cannot.

The slit lamp is a microscope with an adjustable beam of light. The examiner works forwards through the eye — lids, lashes and tear film, then cornea, front chamber, iris and lens — grading cataract, characterising corneal disease and spotting inflammation. With an additional lens held in front of the eye it also gives a magnified, three-dimensional view of the optic disc and the retina. Pressure is measured here too; the methods and what the number means are covered under eye pressure.

The visual field test

A visual field test measures the sensitivity of vision point by point across the area an eye can see while staring straight ahead. It answers what a person can actually see, as distinct from what their nerve looks like, and it is the reference test for glaucoma damage as well as for anything pressing on the visual pathway.

The experience is honestly reported as tedious. One eye is covered, the chin goes on a rest, and you look steadily at a central target inside a lit bowl while small lights of varying brightness appear in the periphery and you press a button each time you think you see one. It takes several minutes an eye, it is mentally tiring, and almost everyone finishes convinced they have done badly. Two things are worth knowing: the machine deliberately shows lights too dim to see, so missing them is part of the design; and it records whether you kept fixating and whether you pressed when nothing was shown. Those reliability indices decide whether the result can be believed at all.

The learning effect is real — the first test is usually the worst anyone does — which is why an abnormal first field is confirmed by repeating it rather than acted on immediately. The standard glaucoma program samples the central region; a finer pattern is used when damage approaches fixation. Comparability is everything: the same program on the same machine type, or the sequence starts again.

The shape of a defect carries information beyond glaucoma. Loss that respects the vertical midline in both eyes points behind the eye, to the optic pathway rather than the retina, and that finding is worked up as a neurological question with neurology rather than as an eye disease.

OCT scan of the eye

An OCT scan of the eye — optical coherence tomography — uses light to build a cross-section through the retina and optic nerve head, resolving individual layers at a scale close to a microscope slide, with no contact, dye or radiation. You rest your chin, look at a target, and it takes seconds.

In glaucoma it measures the thickness of the retinal nerve fibre layer around the disc and the ganglion cell layer at the macula, comparing both against a normative database and, more importantly, against the same eye’s previous scans. Thinning is detectable before a visual field defect appears, so OCT is the early-warning instrument and the field test is the functional one. In retinal disease it shows fluid, swelling, membranes and holes directly, and it is what makes injection treatment measurable.

The limits deserve equal billing. OCT measures structure, not sight; it cannot say what a person sees. In advanced glaucoma the nerve fibre layer reaches a floor below which it cannot thin further, so scans stop showing change while the field continues to deteriorate — at that stage the field test takes over as the measure of progression. Very short-sighted eyes, tilted discs and previous laser vision correction all confuse the normative comparison and generate false alarms. And the software sometimes mislabels the layers, so a scan is read as a picture, not as a set of numbers.

Gonioscopy and corneal thickness measurement

Gonioscopy answers a question no scan replaces: is the drainage angle open or closed? The angle cannot be seen directly because of the way light bends at the cornea, so a mirrored contact lens is placed on the numbed eye at the slit lamp and the examiner looks around the angle mirror by mirror. It takes a couple of minutes and feels like light pressure, with the lens gel blurring vision briefly. It separates open-angle from angle-closure glaucoma, which changes the entire treatment path, and no glaucoma diagnosis is complete without it.

Pachymetry measures corneal thickness, either by a light probe touching the numbed cornea or by an optical scan with no contact. It is used twice over. Its effect on pressure readings and its status as an independent risk factor belong under eye pressure; its role in deciding whether a cornea can safely have tissue removed belongs under who laser correction suits.

Photographs of the optic disc and the retina

A colour photograph of the optic disc is a permanent record of what a nerve looked like on a given date, and comparing photographs years apart remains one of the most reliable ways to detect slow change — a small disc haemorrhage at the rim is a recognised sign of ongoing damage and is easily missed on a single look. Wide-field retinal imaging captures much of the retina in one shot, often without dilating the eye; it supplements a dilated examination rather than replacing it, because the far periphery is still assessed better by an examiner with a lens.

Dye tests and blood-flow imaging

Fluorescein angiography follows the retinal circulation in real time. A yellow dye is injected into a vein in the arm and photographs are taken rapidly as it reaches the eye, showing where vessels leak, where they are blocked and where new abnormal vessels have grown. The injection can produce a brief wave of nausea, the skin takes a faint yellow cast for a few hours and the urine turns bright orange for a day. OCT angiography maps retinal blood flow with no injection at all, by detecting movement between repeated scans — quick and repeatable, but covering a smaller area and unable to show leakage, which is precisely what dye still exists for.

Scans of the cornea, and ultrasound when the view is blocked

Corneal topography and tomography map the curvature and thickness of the cornea across its whole surface, revealing irregularity and early thinning long before vision is affected. This is the screening test that detects keratoconus and the one that disqualifies some laser candidates. Specular microscopy counts the endothelial cells on the inner surface of the cornea, the single layer of pump cells that keeps it clear and does not regenerate, and it matters in the follow-up of a corneal transplant. Biometry measures the length of the eye and the curvature of the cornea to calculate implant power; how that drives lens choice is covered under choosing the lens.

When the inside of the eye cannot be seen at all — a dense cataract, blood in the vitreous, a scarred cornea — a B-scan ultrasound probe on the closed eyelid builds a picture through the opacity. It is painless, takes a few minutes, and answers a small number of urgent questions well: whether the retina is attached, whether there is a mass, whether the vitreous has separated.

When a retina specialist is involved

Ophthalmology divides into subspecialties, and the tests follow those divisions. A retina specialist is an ophthalmologist who has trained further in diseases of the retina, macula and vitreous; they read macular OCT and angiography, give intraocular injections and operate inside the back of the eye. A glaucoma specialist reads disc imaging, nerve fibre scans and visual fields, performs gonioscopy and does the pressure-lowering operations.

Being redirected to a retina specialist after a scan is not an escalation in seriousness; it means a finding sits in someone else’s daily work. The conditions that most often lead there are macular degeneration, diabetic eye disease, retinal vein occlusion, retinal detachment, macular holes and membranes treated by vitrectomy, and the sudden onset of floaters and flashes.

What the tests cannot answer

No single test diagnoses glaucoma, and no combination of tests done on one day can distinguish a nerve that is damaged and stable from one that is actively deteriorating. That distinction requires the same tests repeated over time and compared like with like. It is why a first appointment can end with a diagnosis of “suspect” and a date to repeat everything — a real answer, not an indecisive one.

Results are also read against a person, not against a database: a measurement flagged red because it differs from a normative average can be entirely normal for a very short-sighted eye or an unusually small optic disc. Practical matters around the visit itself — dilated pupils, timing and how results are reported — are covered under practical notes.

Macular degeneration: dry, wet, and what changes when it turns

Macular degeneration is the progressive loss of the small central patch of retina that produces sharp, detailed sight. In its usual form it is called age-related macular degeneration, or AMD, and it is the reason a person can be unable to read a newspaper while still walking unaided around an unfamiliar room. Most people meet the term on an optician’s referral letter mentioning drusen at the macula, or on the day straight lines started to bend.

What the macula does, and why losing it is different from going blind

The retina is a sheet of light-sensitive tissue lining the back of the eye. Almost all of it is built for a rough, wide, motion-sensitive picture — the picture that lets you cross a road. Only a tiny central area, the macula, is built for detail, and it does the work of reading, recognising a face, and reading a road sign.

That division explains how the disease behaves: it attacks the detail and leaves the map. People with advanced AMD describe a blank or distorted patch sitting exactly where they are looking, while the edges of the world stay perfectly visible. They are not in the dark. What they cannot do is see the face of the person they are talking to.

Dry macular degeneration and geographic atrophy

The dry form is far the more common. Beneath the retina sits the retinal pigment epithelium, a layer that services the photoreceptors and clears their waste. With age that clearance falters and yellowish deposits called drusen accumulate underneath. Small scattered drusen are an ordinary finding in older eyes; large, numerous or confluent drusen mark genuine intermediate disease, and they are why someone with normal vision is told they have early macular degeneration.

Dry AMD progresses over years. Its advanced stage is geographic atrophy: sharply outlined patches where the pigment epithelium and the photoreceptors overlying it have died. The patches enlarge gradually and often spare the very centre until late, which is why some people keep useful reading vision longer than their retinal appearance suggests, then lose it comparatively quickly when atrophy reaches the fovea.

No treatment restores retina that has already atrophied. Treatments designed to slow the enlargement of atrophy have appeared in recent years; what they do is slow the growth of a measured area. They do not rebuild photoreceptors and do not return reading vision, and their availability differs between countries. Anyone told that dry AMD can be cured has been told something untrue.

Wet AMD: new vessels, leakage, and speed

Wet AMD is the less common form and causes most of the rapid, severe central loss attributed to the disease. In wet macular degeneration, abnormal new vessels grow from the choroid — the vascular layer under the retina — and break through into or under the macula. These vessels are structurally poor. They leak fluid and they bleed.

The critical difference is timescale. Dry AMD is measured in years; wet AMD in weeks. Fluid collecting within and under the macula lifts the photoreceptors out of position, which is why the earliest symptom is distortion rather than blur. Untreated, leakage and bleeding are eventually replaced by fibrous scar at the centre of vision, and a scarred macula does not recover. Almost all the vision modern treatment saves is saved before that scar forms, which is why an eye that has newly turned wet is treated without delay. The treatment is set out in injections into the eye.

Dry disease can turn wet at any point, including in an eye stable for a decade, and in the second eye of someone whose first eye was treated years ago. Turning wet is an event, not a stage that arrives on schedule.

Macular degeneration symptoms, and how dry and wet disease are told apart

The macular degeneration symptoms people report fall into a consistent set:

• Distortion. Straight lines bend, bow or kink — door frames, the edge of a table, lines of text. A face may look pulled to one side. Distortion is the symptom most specific to a macula with fluid in it.
• A central smudge or grey patch that sits where you are looking and travels with your gaze, rather than a shadow at the edge.
• Letters missing from the middle of a line, so reading becomes guessing and re-reading rather than a smooth flow.
• Needing much more light to read, and adjusting slowly on moving from bright light into a dim room.
• Colours looking flat and contrast reduced, so a white plate on a pale cloth becomes hard to make out.
• Faces going blank. The outline and hair remain; the features do not.

Dry and wet disease are separated on examination and on an OCT scan, not on the history: leakage is confirmed by seeing fluid in the macula. Timescale is part of the clinical picture — dry disease progresses over years and wet disease over weeks — but a symptom does not identify which form an eye has, which is why an eye with drusen is scanned rather than judged by how fast it has changed.

The Amsler grid — a printed square of fine lines with a central dot — makes distortion visible before it becomes obvious in ordinary life, and it is used because the second eye hides the first eye’s problem so effectively that a person may notice nothing until both are affected.

What raises the risk of macular degeneration, and what genuinely changes it

Age is the dominant risk factor and cannot be altered. Family history matters, and the genetic contribution is substantial. Pale irises, cardiovascular disease and a diet poor in leafy vegetables and fish are all associated with it.

Smoking is the strongest risk factor a person can actually change. It raises both the risk of developing AMD and the risk of progressing to the advanced forms, by a margin large enough to state plainly rather than bury in a list.

Nutritional supplementation has a real but narrow place. Specific antioxidant and zinc formulations tested in large trials reduced progression in people who already had intermediate dry AMD, or advanced disease in one eye. They did not prevent AMD, did not help early disease, and did not improve anyone’s vision. One point is a safety matter: formulations containing beta-carotene are avoided in current and former smokers, which is why the composition of a supplement belongs to a doctor.

What treatment can and cannot do in macular degeneration

Treatment for wet AMD suppresses leakage, often dramatically in the first months, but it is ongoing rather than curative. What treatment cannot do is rebuild macula already destroyed, whether by atrophy in the dry form or by scar in the wet. Vision lost to a disciform scar does not come back. That is why the wet form is treated urgently while the fluid is still fluid, and why a scarred eye is not injected indefinitely in the hope of a change that cannot happen.

The part of AMD care most often left out is low-vision rehabilitation, and it is not a consolation prize. Magnification chosen for the task, high task lighting, enlarged light-on-dark screen text, and eccentric viewing training — using a healthy patch of retina just off centre to read with — measurably change what a person with advanced macular degeneration can still do.

Injections into the eye: what an intravitreal injection is, and why they repeat

An intravitreal injection is the delivery of a drug directly into the vitreous cavity — the gel-filled space occupying most of the volume of the eye — through the white of the eye with a very fine needle. It is now among the most frequently performed procedures in ophthalmology, and the treatment behind almost every case of preserved central vision in wet AMD, diabetic macular swelling and retinal vein occlusion. The gap between how it sounds and what it is actually like is probably the widest in the speciality.

What an anti-VEGF injection is actually doing

Vascular endothelial growth factor, VEGF, is a signalling protein that tells blood vessels to grow and become leaky — a normal molecule doing a normal job. In a retina short of oxygen or diseased, it is over-produced, and the retina does what the signal instructs: it grows fragile new vessels, and the vessels leak.

An anti-VEGF injection puts a drug into the eye that binds that signal locally. Vessels stop leaking, fluid is reabsorbed, the macula flattens towards its normal contour, and in many eyes vision improves as photoreceptors return to their proper position.

Two features of that mechanism explain everything else. First, the drug has to be inside the eye: drops do not reach the retina in useful concentration, and a tablet strong enough to do so would expose the whole body to a drug that interferes with blood vessel growth. Second, the drug blocks a signal — it does not remove the vessels responding to it, and it does not switch off the disease producing it. When the drug clears, the signal is still there. That is the entire reason injections repeat.

What an intravitreal injection appointment is like, minute by minute

An intravitreal injection visit has two halves. The first is assessment: vision is measured, the pupil dilated, and the macula scanned before anything is decided. The scan is what the decision is made from, because fluid can be present in a macula whose owner reports no change and absent in an eye that feels worse. What the scan shows and cannot show is covered in the tests, and what each one answers.

The second half happens in a clean procedure room rather than the consulting chair, and the sequence is consistent:

• Anaesthetic drops, usually more than one round, sometimes with a gel left against the surface for a few minutes. The eye becomes numb and slightly odd-feeling.
• Antiseptic. A povidone-iodine solution is applied to the lids, lashes and surface of the eye. This is the step people remember, because it stings and makes the eye water. It is also the single most important one: it is what keeps infection inside the eye as rare as it is.
• A drape and a lid clip. A small sterile sheet covers the face, and a light spring clip holds the lids open. Being unable to blink for two minutes feels strange rather than painful, and provokes most of the anxiety.
• The injection. You are asked to look steadily away from the site. The needle enters through the white of the eye a few millimetres behind the edge of the cornea, at the pars plana — a flat band with no retina behind it. Most people feel pressure and nothing more. It takes a few seconds.
• Afterwards. The clip comes out, the eye is rinsed of iodine, and vision is often checked in the crudest way — counting fingers — before you leave.

What the injection feels like, and the hours afterwards

For the rest of the day the eye is usually gritty, scratchy and watery, as though something is in it. Almost all of that comes from the iodine and the lid clip drying the surface, not from the needle, and it settles overnight in most people.

A bright red patch on the white of the eye is common where the needle passed and looks far worse than it is. It is a subconjunctival haemorrhage: painless, harmless to vision, and it fades over one to two weeks through the same colours as a bruise.

Many people see the drug itself — small dark specks or a wobbling bubble drifting across vision for a day or two as the injected volume disperses in the gel. It is disconcerting and normal. The pupils stay wide for several hours, which rules out driving. The eye does not see better on the day of an injection; improvement follows the reabsorption of fluid over days and weeks.

Why one injection is never the plan

Treatment almost always opens with a loading course — a short series of injections given roughly a month apart — before the response is judged. A single dose in an actively leaking macula produces a temporary improvement that fades; the state of a macula after several consecutive doses is a far better guide to what an eye can achieve.

After loading, the macula is reassessed and the strategy set. This is where expectations collide with reality. People hear “a course of injections” and reasonably understand it as they would a course of antibiotics: a defined number, then finished. Wet AMD, diabetic macular swelling and vein occlusion are chronic conditions, and anti-VEGF treatment is closer to blood pressure medication than to an operation — it works while it is being given.

Stated plainly: for many people treatment is measured in years. Some eyes become genuinely quiet and treatment stops; some need injections at long intervals indefinitely; some, particularly in diabetic disease, need them frequently for a long period. Nobody can tell at the first visit which an individual eye will be, and a number quoted at the outset would be an invention.

Treat-and-extend, and how the interval is decided

There are three broad ways to schedule injections after loading, and they differ in a way worth understanding.

• Fixed interval. Injections at a set spacing regardless of findings. Simple and predictable, and it treats some eyes more often than they need.
• As-needed retreatment. The eye is scanned at intervals and injected only when fluid is present. It sounds efficient and has one structural weakness: the disease has to become active again to be detected, and each episode of recurrent fluid tends to cost a little vision that is not always recovered.
• Treat-and-extend. The eye is injected at every visit, and the interval to the next is lengthened while the macula stays dry and shortened as soon as fluid returns. The eye is never deliberately allowed to become wet, and the interval is discovered individually rather than assumed.

Treat-and-extend has become the dominant approach in most units for exactly that reason, and it is why two people with the same diagnosis can be on very different schedules without either being mismanaged. What sets any individual interval is the scan, the vision, and the treating team’s judgement of how that eye behaved the last time the interval was stretched — not a rule, and not a comparison with someone else in the waiting room.

Steroid implants, and when they are used instead

Not every macula responds to anti-VEGF, and inflammation contributes to swelling in ways VEGF blockade does not fully address. Slow-release corticosteroid implants, injected into the vitreous the same way, are used mainly for macular swelling — most often in diabetic disease and vein occlusion — where anti-VEGF has been insufficient, or where someone genuinely cannot attend often enough. They release drug over months rather than weeks.

They carry two predictable consequences rather than rare complications. The first is raised eye pressure in a meaningful minority of eyes, monitored deliberately; the number itself is explained in eye pressure, and what the number means. The second is cataract, close to inevitable over time in an eye that still has its natural lens — which is why steroid implants are often chosen for eyes that have already had cataract surgery.

The risks of an intravitreal injection

The complication that governs the entire ritual of an intravitreal injection is endophthalmitis — bacterial infection inside the eye. It is rare. It is also devastating when it happens, because the inside of the eye has no blood supply of its own to fight infection with — the reason for the iodine, the drape and the sterile field. It behaves quite differently from ordinary post-injection discomfort: pain that increases over a day or two instead of settling, an eye that becomes progressively red, and vision that drops rather than recovers. It is a hospital emergency and is treated as one, and every unit that gives injections maintains a route for examining an eye that behaves that way.

The other risks are smaller. Eye pressure rises briefly at the moment of injection and settles within minutes. Retinal tear and detachment are described but very uncommon, traumatic cataract from the needle touching the lens is rare, persistent floaters can follow, and some agents cause inflammation without infection. Because a small amount of drug leaves the eye and enters the bloodstream, cardiovascular history is asked about and taken seriously, particularly a recent stroke or heart attack — the systemic exposure is low, but it is not zero.

None of that makes injections optional in an eye with active leakage: the alternative is not a risk-free eye, it is a scarred macula.

What stopping means

Stopping falls into two entirely different categories, and confusing them causes real harm.

The first is planned cessation. An eye that has stayed dry through repeatedly lengthened intervals may be observed without injection, with monitoring continuing. An eye whose macula has scarred or atrophied to the point where fluid control can no longer produce visual benefit is also stopped, and that is a correct decision rather than a failure: continuing to inject a scarred macula exposes an eye to risk for no possible gain.

The second is interruption while the disease is still active, and this is the one that costs vision. When treatment stops in an eye with a live leaking membrane, fluid returns — often within weeks — and vision lost during a recurrence is frequently not fully regained even after treatment restarts. Repeated cycles of recurrence and rescue leave an eye worse than steady control would have, which is why intervals are extended in careful steps rather than by pausing.

Injection fatigue is real and deserves naming rather than judging. Years of repeated visits, dilated afternoons, travel, cost and the low-grade dread that precedes each one wear people down. It is a clinical problem with clinical answers: a longer-acting agent, a genuinely stretched interval, or a frank reassessment of whether an eye is still gaining anything. Where the burden is the problem, the answer is a different plan rather than an abandoned one.

Diabetic eye disease: diabetic retinopathy and diabetic macular oedema (diabetic macular edema)

Diabetic retinopathy is damage to the small blood vessels of the retina caused by prolonged exposure to high blood glucose. It is a leading cause of sight loss in working-age adults, and its defining characteristic is that it is well advanced before it produces any symptom. The retina is also the one place in the body where blood vessels can be examined directly, which is why what is visible there says something about kidneys and nerves as well as eyes.

How diabetes damages the retina

Persistently high glucose damages the walls of retinal capillaries. Supporting cells are lost, walls weaken and bulge into microaneurysms, and the barrier that keeps blood inside the vessel begins to fail. At the same time, capillaries close off and stop carrying blood at all.

Those two processes — leakage and closure — produce the two halves of diabetic eye disease. Leakage lets fluid, protein and fat escape into retinal tissue; at the macula, vision is affected directly. Closure starves retina of oxygen, and starved retina produces VEGF, which drives the fragile new vessels behind the sudden, dramatic events.

The stages, from background changes to proliferative diabetic retinopathy

• Background, or mild non-proliferative retinopathy. Microaneurysms and small dot haemorrhages. No symptoms and no treatment — but a definite finding, because it establishes that damage has begun and changes how closely the eyes are watched.
• Moderate to severe non-proliferative retinopathy. More extensive haemorrhages, fatty exudates, beaded veins and areas of capillary closure on imaging. Still frequently symptom-free. Severe non-proliferative disease is the point at which the risk of progressing to new vessel growth becomes high.
• Proliferative diabetic retinopathy. New vessels grow on the retinal surface or the optic disc. They are structurally abnormal and attached to the vitreous gel. They bleed into the vitreous, producing sudden painless loss of vision — see vitrectomy — and they are accompanied by fibrous tissue that contracts over months, pulling the retina forward into a tractional retinal detachment.
• Advanced complications. New vessels can also grow on the iris and in the drainage angle, blocking outflow and producing neovascular glaucoma, a painful and difficult form of the condition described in glaucoma.

Diabetic macular oedema (diabetic macular edema)

Diabetic macular oedema (diabetic macular edema) is the accumulation of fluid within the macula as a result of leaking retinal capillaries, and it is the most common reason people with diabetes lose reading vision. Macular edema is swelling of the tissue itself, not a growth and not a bleed: the retinal layers thicken and separate, and photoreceptors that depend on precise architecture stop reporting accurately.

Its most important feature is that it is not tied to the stage of retinopathy. An eye with only mild background changes can have significant diabetic macular oedema, and an eye with extensive proliferative disease can have a dry macula — which is why the macula is scanned rather than judged by how the rest of the retina looks.

Optical coherence tomography measures the swelling in cross-section and settles the decisive question: whether the fluid involves the very centre of the macula. Centre-involving oedema threatens reading vision and is treated; oedema outside the centre may be monitored. Symptoms, where there are any, are blur that glasses do not correct, distortion, and difficulty reading in an otherwise normal-feeling eye.

Screening: why it is annual, and why it happens while vision is normal

Diabetic eye screening exists because of a single mismatch: the point at which retinopathy becomes treatable comes long before the point at which it becomes noticeable. By the time vision drops, the opportunity to prevent that drop has generally passed. Screening is therefore an examination of people who feel well.

The principles are consistent internationally, even where exact schedules differ:

• Everyone with diabetes has a retinal examination through a dilated pupil, or standardised retinal photographs, at a defined interval — conventionally at least once a year when the retina is normal.
• In type 2 diabetes, screening begins at diagnosis, because the condition is frequently present for years before it is identified and retinopathy can already exist on the day of diagnosis.
• In type 1 diabetes, screening begins some years after diagnosis and around puberty, because retinopathy is uncommon before then.
• The interval shortens as findings accumulate. An eye with moderate or severe non-proliferative changes is seen far more often than annually, and an eye under treatment is on a treatment schedule rather than a screening one.
• Pregnancy accelerates retinopathy, sometimes markedly, so screening is more frequent through pregnancy and after delivery. This is planned with the obstetric team in gynecology and obstetrics.

One counter-intuitive point belongs here. A rapid, large improvement in glucose control can transiently worsen retinopathy before improving it. This is well recognised, and it is emphatically not an argument against improving control — it is an argument for the eyes to be examined around the time control changes substantially.

Laser, injection or surgery: how the choice is made

Panretinal photocoagulation is the long-established treatment for proliferative disease. Laser burns are applied across the peripheral retina, deliberately destroying starved tissue so the eye stops producing the VEGF driving new vessel growth. The logic is a straightforward trade: peripheral retina is sacrificed to protect central retina. The cost is permanent — reduced peripheral field, reduced night vision, and for some people a noticeable change in driving after dark. Focal and grid laser has a narrower role now, mainly for leakage that does not involve the very centre.

Anti-VEGF injections have become first-line for centre-involving diabetic macular oedema, and they also cause new vessels to regress. Their weakness in diabetic disease is not efficacy but dependence on attendance: the effect wears off. Laser retains an important place precisely because its effect does not lapse. Steroid implants are used for oedema that resists anti-VEGF. How all of these are given is described in injections into the eye.

Vitrectomy is used when bleeding into the vitreous fails to clear, when it prevents the laser treatment the eye needs, or when scar tissue is dragging the retina off the wall of the eye.

What glucose control does for the eyes, and what it does not

Long-term glycaemic control, blood pressure control and lipid management all slow the development and progression of diabetic retinopathy. What control does not do is reverse damage already present. Microaneurysms do not disappear because a glucose reading improves, closed capillaries do not reopen, and laser scars are permanent. Duration of diabetes remains the strongest single determinant and is the one variable nobody can alter, which is why a person with excellent control can still develop retinopathy after decades and should not be treated as though they caused it.

The eye unit does not manage diabetes. Glucose targets, medication choices, insulin regimens and the metabolic work-up sit with the diabetes team — at Acıbadem, with endocrinology — and the ophthalmologist’s contribution is to report what the retina shows and treat what it finds.

Retinal detachment

A retinal detachment is the separation of the retina from the layers beneath it that supply it with blood and nutrients. It is painless, it is not visible from outside the eye, and it is one of the few conditions in ophthalmology where the time between onset and repair genuinely changes what vision is left afterwards.

What a retinal detachment actually is

The retina’s outer layers have almost no blood supply of their own; the photoreceptors are fed by the choroid through the pigment epithelium directly beneath them, an arrangement that works only because the two surfaces are held in close contact.

When the retina lifts away, photoreceptors are separated from the tissue that feeds them. They do not die instantly, but they deteriorate, and the longer separation lasts the less complete their recovery. The description of retina peeling like wallpaper is accurate about the mechanics and misleading about the consequence: this wallpaper is living tissue fed by the wall.

The symptom pattern follows the geometry. A detachment usually begins in the periphery, so the first change is a dark shadow or curtain encroaching from one side, corresponding to the opposite part of the retina. Vision through the detached area is not blurred — it is absent. Central vision stays sharp until the detachment reaches the macula, at which point it drops steeply.

How a tear becomes a detachment

Most detachments are rhegmatogenous, meaning they start with a break in the retina. The sequence begins with ageing of the vitreous gel, described in floaters and flashes. As the gel liquefies and separates it pulls at points where it is unusually firmly attached, and where the pull exceeds what the retina can withstand, it tears.

A tear on its own is not a detachment. It becomes one when liquefied vitreous passes through the opening and collects underneath the retina, lifting it off the wall like water getting behind a seal. This is why a tear sealed before fluid tracks through it usually prevents the detachment entirely, and why the same event can be a minor outpatient procedure one week and an operation the next.

Two other mechanisms exist. Tractional detachment occurs when fibrous tissue contracts and pulls the retina forward without any tear — the pattern in advanced diabetic eye disease. Exudative detachment occurs when fluid accumulates under an intact retina because of inflammation, a tumour or a vascular abnormality; there is no hole to close, and treatment is directed at the cause.

Who is at higher risk of retinal detachment

• Short-sightedness, increasingly so with increasing degree. A myopic eye is longer, its peripheral retina thinner, and its vitreous liquefies sooner. This is the single most important predisposing factor.
• A detachment in the other eye. The eyes are a matched pair with matched anatomy, and the fellow eye carries a materially higher risk.
• Previous intraocular surgery, including cataract surgery and previous vitrectomy. The risk after modern cataract surgery is small, but real and lasting, which is why a change in floaters in an eye operated on a decade ago is still taken seriously.
• Blunt trauma, sometimes with months between the injury and the detachment.
• Lattice degeneration and other peripheral retinal thinning, often found incidentally.
• Family history, and inherited connective tissue conditions such as Stickler and Marfan syndromes, in which detachment can occur young and in both eyes.

Why retinal detachment is repaired urgently

The urgency has nothing to do with pain, because there is none. It has to do with photoreceptor survival: detached photoreceptors are cut off from their supply and degenerate progressively, and the recovery of vision after reattachment falls as the duration of detachment rises.

The decisive anatomical question is whether the macula is still attached. An eye in which the detachment has not yet reached the centre is macula-on, and here surgery is preventive — central vision is currently normal and the object is to keep it that way, so these eyes are operated on within a very short window. An eye in which the detachment has crossed the macula is macula-off; central vision has already dropped and some photoreceptor loss has occurred, and while repair remains necessary, the timing pressure is different in character.

This is why retinal detachment is treated as emergency surgery in every eye unit that performs it — a statement about the biology of the tissue, not about how a person feels on the day.

Sealing a tear before the retina detaches

A retinal tear found before fluid has tracked under it is dealt with by creating a controlled scar around the break, welding it to the wall of the eye so it cannot extend.

Laser retinopexy is done in the clinic with the pupil dilated and a contact lens on the eye, placing rows of burns around the tear. It takes minutes and is uncomfortable rather than painful — bright flashes with a deep, dull ache behind the eye. Cryotherapy achieves the same adhesion by freezing from outside the eye, and is used where a tear is too far forward or the view is obscured by blood. It is achier, and the eye is red and swollen for a few days.

Both are preventive procedures with real limits. They seal the treated break, but they do not remove the floaters that accompanied it, they take days to reach full adhesive strength, and they do not prevent a new tear forming elsewhere in a retina still undergoing vitreous separation — which is why further examination is normally arranged rather than the episode being closed.

Scleral buckle, and the operations it competes with

A scleral buckle is a silicone band or sponge sewn onto the outside of the eye and tightened so the wall is indented inwards until it meets the detached retina and closes the tear. The whole operation is performed outside the eye, so the natural lens is left undisturbed — the main reason buckling remains preferred in younger eyes with a clear lens and a formed vitreous, where vitrectomy would guarantee a cataract.

Its trade-offs are specific. Indenting the eye lengthens it, producing a shift towards short-sightedness and often a change of prescription. The eye aches for weeks and looks red for longer than patients expect, and double vision occurs occasionally where the band interferes with the muscles that move the eye. The band is generally left in place permanently.

Two other approaches compete with it. Pneumatic retinopexy injects a gas bubble in the clinic and uses head positioning to press it against a single tear in the upper retina, with laser or freezing to seal it. It is the least invasive option, suits a narrow group, and fails more often than the alternatives; a failed attempt is followed by a formal operation. Vitrectomy, described in vitrectomy, has become the most common repair, particularly where the lens has already been replaced, where there are multiple or posterior tears, or where the view is obscured by blood. The choice is made from the anatomy — where the breaks are, how many, how long the detachment has been present, and whether the eye still has its natural lens. There is no universally superior operation.

What vision comes back after retinal detachment repair, and what does not

Reattaching a retina is a mechanical achievement; restoring vision is a biological one, and the two do not always arrive together. An eye repaired while the macula was still attached usually keeps its central vision. An eye repaired after the macula detached usually improves substantially but frequently does not return to what it was: persistent distortion, a difference in image size between the eyes, reduced contrast and slower reading are common even after a technically perfect repair. Recovery continues over months rather than weeks.

Some retinas detach again. The commonest cause is proliferative vitreoretinopathy, in which cells proliferate on the retinal surface and contract into membranes that pull the retina off once more, typically in the weeks after the first operation. It is the principal reason a person needs more than one procedure, and it is a feature of the disease rather than evidence that something was done badly.

Vitrectomy

Vitrectomy is the surgical removal of the vitreous gel from inside the eye, performed to gain access to the retina, to relieve pulling on it, or to clear material that has made the eye opaque. It is the core operation of retinal surgery.

What a vitrectomy is, and what the vitreous does

The vitreous is a clear gel filling the large cavity behind the lens. In childhood it is firm and structural; over decades it liquefies, collapses and separates from the retina. Its structural role in an adult eye is negligible and its optical role is simply to be transparent — which is why it can be removed, and why the eye works perfectly well with clear fluid in its place.

The operation is a pars plana vitrectomy: three tiny ports are placed through the white of the eye at the pars plana, the safe band with no retina behind it. One carries an infusion line that keeps the eye at pressure, one carries a light, and one takes the instruments — a cutter that removes gel in minute bites, forceps fine enough to grasp a membrane a few cells thick, and laser probes. The instruments are around half a millimetre across, and the ports usually seal themselves without stitches.

Most vitrectomies are performed under local anaesthesia (local anesthesia), with the eye numbed and immobilised by an injection around it, the patient awake and often lightly sedated. General anaesthesia is used for long or complex cases, injured eyes, and children. The eye sees light, colour and movement during surgery; it does not see the operation.

Macular hole

A macular hole is a full-thickness defect at the very centre of the macula, created when the vitreous pulls on the fovea as it separates. The symptom is distinctive: a small dense black or grey spot exactly in the centre of vision in one eye, with distortion around it, and a straight line that appears broken where it crosses.

People frequently confuse a macular hole with macular degeneration, and they are entirely different problems. A macular hole is a mechanical injury caused by traction and it is repairable by surgery; macular degeneration is a degenerative and vascular disease and it is not.

Repair consists of vitrectomy, peeling of the internal limiting membrane — the retina’s innermost surface layer — from around the hole to release traction, and a gas bubble to hold the edges flat while they close. Face-down positioning is prescribed for a period the surgeon specifies. The operation closes most holes. What it does not reliably do is return vision to normal: recovery depends strongly on how small the hole was and how long it had been open, and a hole present for a year behaves very differently from one found within weeks.

Epiretinal membrane

An epiretinal membrane, also called macular pucker, is a fine sheet of cells growing across the surface of the macula and then contracting, wrinkling the retina beneath it. It usually follows vitreous separation and is often found incidentally in an eye with no complaint at all.

Where it does cause symptoms they are characteristic: straight lines that bow or ripple, letters that seem crowded together, a difference in image size between the eyes, and blur a new pair of glasses does not fix.

The important clinical fact is that many epiretinal membranes never progress and never need anything done. Surgery is offered for symptoms that interfere with a person’s life, not for an untidy scan, and an eye that reads well with a visible membrane is usually left alone and monitored. Where surgery is done it is vitrectomy with peeling of the membrane, often with the internal limiting membrane beneath it; gas is frequently unnecessary, so positioning is often not required. Recovery of distortion is slow and usually partial — a retina wrinkled for a long time does not flatten completely.

Vitreous haemorrhage (vitreous hemorrhage)

A vitreous haemorrhage (vitreous hemorrhage) is bleeding into the vitreous cavity. Because the gel is normally perfectly clear, even a small quantity of blood scatters light dramatically, and vitreous hemorrhage therefore produces symptoms out of all proportion to the amount of blood:

• A sudden shower of dark specks.
• A red or brown haze.
• Painless loss of all useful vision in that eye within minutes, in a dense bleed.

The causes are what matter, because the blood itself is not the disease. Proliferative diabetic retinopathy is the commonest. Retinal vein occlusion, a torn retinal vessel during vitreous separation, a retinal detachment and trauma account for most of the rest.

Blood that obscures a patient’s view also obscures the surgeon’s, so ultrasound is used to look through it for a detachment hiding behind the opacity. Many haemorrhages clear on their own over weeks as blood is absorbed, and observation is reasonable when the retina is known to be attached. Vitrectomy is chosen when the blood fails to clear, when it prevents laser treatment the eye urgently needs, when bleeding recurs, or when a detachment is suspected behind it.

The gas bubble, positioning, and why flying is not possible

At the end of many vitrectomies the eye is filled with a gas bubble. Gas floats, and its surface tension presses the retina or the edges of a hole against the wall of the eye while adhesion forms. The bubble is absorbed over the following weeks, and short-acting or long-acting gases are chosen according to how long that tamponade needs to last.

Seeing through gas is a strange experience. At first vision is very poor. As the bubble shrinks a horizontal line appears across vision — the meniscus — which wobbles when the head moves, like looking at the surface of water from underneath, and descends over days and weeks until the last small bubble disappears.

Positioning is the part patients underestimate. Because gas rises, the head has to be held so the bubble sits against the part of the retina being treated — face-down for a macular hole, or on one side for a break in a particular quadrant. The instruction is specific to the operation and is given by the surgeon. It is genuinely hard: it interferes with sleeping, eating and using a phone, and it hurts the neck and back. Poor positioning is one of the avoidable reasons an operation fails.

Flying with gas in the eye is not possible, and this is an absolute rather than a cautious rule. As ambient pressure falls in a climbing aircraft cabin, the gas bubble expands. In a closed eye that expansion raises the intraocular pressure sharply, which can shut off the blood supply to the retina and optic nerve and cause permanent, total loss of vision in that eye. The same applies to any significant gain in altitude, including high mountain roads. The bubble is not counted out in days: the surgeon confirms by examination that it has gone before such travel is possible. For the same reason nitrous oxide is avoided in any anaesthetic given while gas is in the eye, because it diffuses into the bubble and expands it — so intraocular gas is recorded and flagged to any anaesthetist involved in an unrelated operation for as long as the bubble remains. Sequencing around this constraint for people travelling from other countries is set out in coming from abroad.

Silicone oil, and why it comes out again

Where a longer or more reliable tamponade is needed, silicone oil is used instead of gas — in complicated detachments, in eyes with extensive scar tissue, in eyes that have already re-detached, and in people who cannot position or who genuinely must fly.

Oil has real advantages. It does not expand with altitude, so air travel is possible with oil in the eye, and vision through oil, while not normal, is better than vision through fresh gas.

It is not a permanent solution. Oil accelerates cataract in an eye with its natural lens, can raise eye pressure, and can emulsify into droplets that disperse through the eye. It is therefore usually removed at a second, planned operation once the retina is stable — part of the treatment plan from the start rather than a complication, though people not told about it in advance experience it as a setback.

The day of a vitrectomy, and the weeks that follow

The day itself is mostly waiting: drops dilate the pupil over an hour or more before anything begins. Length varies enormously — a straightforward membrane peel is quick, a complex detachment with scar tissue is not. Many patients go home the same day; some stay overnight, particularly where positioning needs supervising.

The eye is padded and shielded at first, and a shield is usually worn at night for a period. Drops are used for weeks — an antibiotic, an anti-inflammatory, sometimes a pressure-lowering drop — on a schedule set by the operating team. Discomfort is typically a dull ache and a gritty surface rather than sharp pain, and the eye stays red for longer than most people expect. Return to ordinary activity depends far more on the tamponade and the positioning requirement than on the surgery itself, so there is no single number of days that applies to every eye.

Cataract after vitrectomy, and the other risks

The most predictable consequence of vitrectomy in an eye that still has its natural lens is cataract. Removing the vitreous changes the oxygen environment around the lens, and the lens clouds — usually within a year or two, faster where gas or oil was used. This is expected rather than exceptional and is treated in the ordinary way described in cataract surgery. An eye that has already had cataract surgery has nothing further to lose here, which is one reason vitrectomy is chosen more readily in those eyes.

The other risks are those attaching to any intraocular surgery:

• Raised eye pressure, particularly with gas or oil.
• Infection inside the eye — rare and serious.
• New retinal breaks or detachment.
• Bleeding.
• Small permanent blind spots near the centre, after peeling of the internal limiting membrane, that most people never notice but that exist.

Set against that list is the reason the operation is offered at all. Vitrectomy is done on a seeing eye when the natural course of the condition is worse than the operation — a macular hole that will not close on its own, a detachment that will progress, a haemorrhage preventing sight-saving treatment. An ophthalmologist declining to operate on a mildly symptomatic membrane in a well-seeing eye is applying that principle rather than withholding treatment.

Floaters and flashes

Floaters are small shapes that drift across vision — dots, threads, cobwebs, rings or a fine haze — that move with the eye and lag behind it when it stops. They are shadows cast on the retina by opacities suspended in the vitreous gel, which is why they follow eye movement, drift with gravity, and are most visible against a plain bright background such as a white wall, a blue sky or a screen.

Posterior vitreous detachment: the common explanation

Posterior vitreous detachment is the age-related separation of the vitreous gel from the surface of the retina, and it is why most people develop new floaters. The gel liquefies over decades, collapses inward and peels away from the retina behind it. It is close to universal eventually, it occurs sooner in short-sighted eyes and in eyes that have had cataract surgery, and it is a normal ageing change rather than a disease.

What it produces is characteristic. A large new floater appears, often described as a ring, a fly or a tadpole — frequently the old attachment point at the optic disc, now floating freely. Flashes accompany it while the gel is still tugging. Both settle. The floater itself does not usually vanish; it drifts out of the line of sight, breaks up, and stops being noticed as the visual system learns to disregard it, over weeks to months.

Flashes, and why the eye reports light that is not there

The retina speaks only one language. Any stimulus reaching it, including a purely mechanical tug from the separating vitreous, is transmitted to the brain as light. That is the whole explanation for photopsia: brief arcs or flickers of light, usually at the edge of vision, most obvious in a dark room and typically provoked by eye movement.

Retinal flashes are worth distinguishing from migraine aura, because the two are frequently confused. Retinal flashes are in one eye, instantaneous, arc-shaped, and worse in darkness. Migraine aura is a phenomenon of the visual cortex, so it affects the same area of the visual field in both eyes; it builds and moves over roughly twenty minutes, shimmers or zig-zags with a jagged edge, and may or may not be followed by headache. The two are separated in clinic rather than by the person experiencing them: an examination of the retina distinguishes a retinal cause from a cortical one, which is why flashes are not attributed to migraine on the description alone.

The uncommon version that matters

In a minority of posterior vitreous detachments the separating gel does not let go cleanly. Where it is firmly adherent it tears the retina, and a tear can go on to become a retinal detachment. The pattern accompanying a tear is different from an ordinary vitreous separation, and describing that difference is the point:

• A sudden shower of many small floaters — soot, smoke, pepper, a swarm — rather than one or two large ones. Those specks are red blood cells from a torn retinal vessel.
• Flashes that are persistent and frequent rather than occasional.
• A dark shadow or curtain moving in from one side and staying there, which does not shift when the eye moves. That is detached retina rather than a floating opacity.
• A sudden painless drop in vision in one eye.

The difficulty — and the reason eye services handle new floaters the way they do — is that at the very beginning the harmless version and the dangerous one can feel identical. A person cannot tell them apart from the inside, and neither can a doctor without looking. The only way to separate them is examination through a fully dilated pupil with the peripheral retina inspected, which is why a sudden change in floaters or flashes is assessed that way rather than by description. A tear found before fluid tracks underneath it is usually sealed as an outpatient procedure; the same tear found after the retina has lifted is an operation.

Eye floaters treatment: what helps, and what is not worth the risk

The honest answer about eye floaters treatment is that for the overwhelming majority of people the correct treatment is none, and that this is a clinical position rather than a shrug.

Floaters improve in three ways without anything being done. They sink or drift out of the visual axis. They break up and become less dense. And, most powerfully, the visual system stops attending to them — neuroadaptation, the same process that stops a person noticing the frame of their glasses. Someone tormented by a floater in month one is frequently unable to find it in month nine, in an eye where it is objectively unchanged.

Nothing taken by mouth dissolves floaters. Supplements and enzyme preparations marketed for them have no credible evidence behind them, and no eyedrop clears the vitreous.

YAG vitreolysis uses a laser to break up a discrete opacity. It suits a narrow group: a single, well-defined, mobile floater sitting clear of both the lens in front and the retina behind. It does not work for the diffuse haze most people complain of, it often produces smaller fragments rather than clearance, and it carries risks including damage to the lens, retinal injury and pressure rise. Many people who ask for it are not candidates, and being told so is the right answer rather than a refusal.

Vitrectomy removes floaters completely, because it removes the gel that carries them. It is also real intraocular surgery on an eye that sees well, with the cataract that reliably follows it and the risks of infection and retinal detachment set out in vitrectomy. It is reserved for floaters that are genuinely disabling — interfering with work, reading or driving — that have been stable for a long period, in a person who has understood the trade honestly. A floater that is annoying is not on its own an indication for surgery.

Living with floaters that stay

Practical adaptations make a measurable difference while adaptation takes hold. Floaters are worst against uniform bright backgrounds, so a white document on a bright screen is the hardest condition. Floaters are least intrusive on a lower-brightness screen, in a brighter room, and against an off-white or dark background rather than a white one; bright outdoor light behaves the same way behind sunglasses.

One distinction is worth holding on to. Floaters stable for years and floaters that changed last week are different clinical objects, even in the same eye. A longstanding pattern that suddenly alters — many more of them, new flashes, or a shadow at the edge — is treated as a new event and examined afresh rather than attributed to the old floaters, because vitreous separation and retinal tears happen in eyes that have had floaters for a decade.

Keratoconus

Keratoconus is a disease of the cornea in which the tissue thins and loses its stiffness, so that normal eye pressure slowly pushes the weakened area forward into a cone. The cornea does most of the eye’s focusing, and a cone-shaped cornea focuses light in several directions at once. The result is not simple short-sightedness. It is irregular astigmatism — a distortion glasses cannot fully neutralise, because glasses correct regular shapes and a keratoconic cornea is not one.

It usually declares itself in the teenage years or early twenties, progresses through the twenties and thirties, and tends to slow in middle age — a tendency, not a guarantee, and not a reason to stop measuring. Almost everyone with keratoconus has some degree of it in both eyes; the second eye is usually several years behind rather than genuinely normal.

Why keratoconus is usually found late

The early disease looks exactly like an ordinary changing prescription. Each visit looks unremarkable on its own. It is the sequence that carries the diagnosis, which is why old prescriptions with their dates are genuinely valuable clinical data.

The other reason is that a standard sight test does not include corneal imaging, and keratoconus is diagnosed on the shape of the cornea rather than on a refraction.

Keratoconus symptoms

The descriptions that make an examiner reach for the topographer are the keratoconus symptoms themselves:

• A prescription that never settles — new glasses every year, with an astigmatism that keeps rotating its axis.
• Corrected vision that is never quite as sharp as the chart says it should be.
• Ghosting or streaking of lights at night.
• Double vision that persists when the other eye is covered.
• Glare.
• An eye that itches and gets rubbed.

How keratoconus is diagnosed

The core test is corneal tomography — a scan mapping the curvature of both the front and the back surface of the cornea and measuring its thickness point by point. Elevation of the back surface and thinning that sits off-centre are the earliest reliable signs, appearing before the front surface looks abnormal and before vision drops. Epithelial thickness mapping adds a further early layer, because the surface cells thin over a developing cone and thicken around it, partially masking it.

Examination at the slit lamp fills in the rest: fine vertical stress lines deep in the cornea, an iron ring around the base of the cone, visible thinning, and in advanced disease a V-shaped indentation of the lower lid on down-gaze. Scarring at the apex, where present, changes what any treatment can achieve.

What keratoconus progression means

Progression is a specific finding, not an impression. It means a measured change over time in the steepest curvature reading, in the thinnest corneal thickness or in the refraction, on repeated scans performed on the same device. Two scans separated by an interval are worth more than any single scan, and a scan taken on one machine is not comparable with one taken on another.

Age is the strongest single predictor: keratoconus diagnosed in a teenager behaves more aggressively than the same appearance found for the first time at forty. Eye rubbing is the one factor a person actually controls, and the association with progression is strong enough that reducing it is part of every management plan — which usually means treating the allergy or the dry surface driving the rubbing rather than simply naming the habit.

Keratoconus treatment, from glasses to surgery

Keratoconus treatment has two entirely separate jobs, and confusing them is the commonest source of disappointment. One job is to stop the cornea getting worse. The other is to make the person see. Nothing does both.

• Glasses work in early disease and stop working when the distortion becomes irregular.
• Rigid gas-permeable, hybrid and scleral contact lenses restore vision by replacing the distorted front surface with a smooth optical one. A scleral lens vaults the whole cornea and rests on the white of the eye, which is why it suits corneas that tolerate nothing sitting on them.
• Corneal cross-linking stiffens the tissue to halt progression. It does not improve the shape in any dependable way.
• Intracorneal ring segments are small clear arcs placed in a channel in the cornea to flatten and regularise the cone. They can move an eye from lens-intolerant back to lens-tolerant. They are a partial correction, not a substitute for lenses.
• Corneal transplant is the last step, reserved for eyes that no lens can correct or in which the apex has scarred. It is described in Corneal transplant.

Laser vision correction is generally not available to a keratoconic eye, because removing tissue from a cornea already too thin and too weak makes the disease worse. Screening for undiagnosed keratoconus is a main reason laser assessment exists at all, and the grounds for turning people down are in Who laser correction suits, and who it does not.

Acute hydrops

Occasionally the innermost layer of a thin cornea splits and fluid from inside the eye floods into the corneal tissue. The eye becomes suddenly painful, red and extremely light-sensitive, and the cornea turns white. This is acute hydrops. It is treated medically in hospital rather than by emergency surgery, and the swelling settles over weeks to months as the break seals itself. What it leaves behind is scarring, and that is a common route to eventually needing a transplant. Hydrops is uncommon and is likelier in advanced disease.

Corneal cross-linking

Cross-linking chemically stiffens the cornea. Riboflavin — vitamin B2 — is soaked into the corneal tissue and activated with a controlled dose of ultraviolet light. The reaction creates additional bonds between the collagen fibres, and a cornea with more of them resists deformation better. Corneal cross linking and corneal cross-linking are the same procedure written two ways; it is also abbreviated to CXL.

What corneal cross linking does, and what it does not do

Corneal cross linking halts. It does not restore. The purpose is to stop a cornea getting steeper and thinner over the following years, so that an eye correctable with a lens today is still correctable with a lens in a decade. It is not a vision-improving operation, and anyone offered it on the understanding that their sight will get better has been given the wrong expectation.

A modest flattening of the cone does happen in some eyes over the year or two afterwards, and the lens fit sometimes improves as a result. That is a bonus, not the objective, and it cannot be promised in advance. Existing scarring does not clear, existing irregular astigmatism does not resolve, and glasses or contact lenses are still needed afterwards.

Who cross-linking is offered to

The clear indication is documented progression: measured steepening or thinning on repeated tomography. A young person diagnosed with keratoconus is often treated on age alone, because the likelihood of progression is high and waiting to prove it means losing tissue meanwhile. A stable cornea in an older adult generally does not need treating. Cross-linking is also used for ectasia that develops after laser vision correction.

The limiting factor is thickness. The treatment needs enough stroma present during the ultraviolet exposure to keep the light away from the cells lining the back of the cornea, and the conventional minimum is around 400 microns. Thinner corneas are either treated with a swelling riboflavin solution to thicken them temporarily, or not treated at all.

What the cross-linking appointment is like

It is done awake, with anaesthetic drops, lying flat, and a clip holds the lids open. In the standard technique the surface layer of cells is removed first, because the epithelium is a barrier riboflavin crosses poorly. Riboflavin drops are then instilled repeatedly while the tissue absorbs them, and the eye is checked to confirm the drug has reached where it needs to be. The ultraviolet exposure follows: a light shines at the eye, there is nothing to feel, and the person keeps looking at a fixation target. A bandage contact lens goes on at the end. Both eyes are not usually treated on the same day, because the recovery is uncomfortable and being unable to see well from either eye at once is avoidable.

Epithelium-off and epithelium-on

Removing the epithelium is the version with the longest and strongest evidence behind it, and it is also the version that hurts. Transepithelial or epithelium-on protocols leave the surface intact, which makes recovery far easier, but riboflavin penetrates less well and the stiffening achieved is generally less. Accelerated protocols shorten the ultraviolet exposure by raising its intensity. These variants are a genuine trade-off between comfort and certainty rather than a settled question, and a unit offering the easier version should say what it is trading away.

Recovery after cross-linking, and the risks

The first days are painful. The removed epithelium has to grow back across the cornea, and until it does the eye stings, waters and cannot tolerate light; pain relief and the bandage lens carry that period. Vision drops before it improves, stays hazy for weeks and settles slowly over months, and most people are not fit to work or travel comfortably at first.

The risks are real and worth stating without softening.

• Infection of an eye with no surface layer — the serious one, and the reason follow-up in the first week is not optional.
• Corneal haze, which occurs in some eyes and usually fades, but can persist and reduce vision.
• Scarring.
• Delayed healing.
• Damage to the inner cell layer in corneas treated at the margins of safe thickness.

And cross-linking sometimes fails: the cornea progresses anyway, and retreatment is then considered.

Corneal transplant

A corneal transplant replaces diseased corneal tissue with clear donor tissue. The cornea has no blood supply of its own, which is why it can be transplanted between unrelated people without tissue matching and without lifelong immunosuppressive drugs — an advantage no other transplanted organ has.

The change of the last two decades is that the whole cornea is no longer routinely replaced. The cornea is a layered structure, most diseases affect one layer, and modern surgery replaces the failed layer and leaves the rest of the eye closed. That single change altered recovery, refractive outcome and rejection risk more than any improvement in technique.

Full-thickness transplant, and the lamellar alternatives

Penetrating keratoplasty removes a circular button through the entire thickness of the cornea and sews a donor button into the gap. It remains the right operation for deep scarring, perforations, failed previous grafts and corneas damaged through their full depth. Its cost is a long recovery, a large amount of induced astigmatism, sutures that stay in for a year or more, and an eye permanently weaker at any future injury.

Deep anterior lamellar keratoplasty replaces the front and middle of the cornea while keeping the patient’s own innermost cell layer, and it suits keratoconus and scarring that has not reached the back of the cornea. The suture burden is similar, but because the recipient’s own endothelium stays in place, endothelial rejection — the kind causing most graft failures — cannot happen.

Endothelial keratoplasty: DSAEK and DMEK

Endothelial keratoplasty is the operation for eyes in which only the inner pumping layer has failed. That layer keeps the cornea clear by continuously removing water from it. When it stops working the cornea waterlogs — corneal oedema — and vision becomes foggy in a way that is worst on waking and improves through the day. Corneal edema is what an endothelial graft is designed to reverse, and Fuchs dystrophy and swelling after cataract surgery are its two common causes.

In DSAEK, a thin disc of donor tissue including the cell layer plus some stroma is inserted through a small incision and held against the back of the cornea with an air bubble. In DMEK, only Descemet membrane and the cells themselves are transplanted — a sheet a few cells thick that rolls up on itself and has to be unrolled inside the eye. DMEK is technically harder and gives sharper vision, quicker recovery and less rejection; the trade is a graft that may not stick first time and sometimes needs a second injection of air.

Operation	What is replaced	Mainly used for	Sutures	Visual recovery
Penetrating keratoplasty	The full thickness of the central cornea	Deep scars, perforation, failed grafts	Stay in for a year or more	Slow; prescription unstable until sutures are managed
Deep anterior lamellar keratoplasty	Front and middle layers; own inner layer kept	Keratoconus, scars sparing the back surface	Similar to a full-thickness graft	Slow, but endothelial rejection cannot occur
DSAEK	Inner cell layer with a thin stromal carrier	Fuchs dystrophy, swelling after cataract surgery	One or two at the entry wound	Weeks to months; the carrier limits final sharpness
DMEK	Descemet membrane and inner cells only	The same conditions, in suitable eyes	Effectively none in the cornea	Faster and usually sharper; may need repeat air

The donor tissue, and the positioning that follows

Donor corneas come from eye banks, which screen for transmissible infection, record the time between death and retrieval, and count the density of the inner cell layer before releasing the tissue. Each cornea is allocated to the operation it suits: a high cell count goes to an endothelial graft, while a healthy front surface with a lower count can still serve an anterior lamellar graft.

After an endothelial graft, the air or gas bubble holding the tissue in place only pushes upward. That means lying flat on the back, face to the ceiling, for a defined period after surgery. It is the single instruction that most determines whether the graft attaches, and it is uncomfortable rather than difficult.

Rejection, failure, and what a transplant will not fix

Rejection means the immune system has recognised the donor tissue, and it is not the same as failure. The classic description is an eye that becomes red, light-sensitive, uncomfortable and blurred over days rather than minutes, and it can begin months or years after surgery. Treated early with intensive topical steroid it is usually reversible; recognised late it destroys the graft. That is why transplant patients are taught the early signs and stay under review indefinitely, and why the steroid drops are reduced slowly under supervision rather than stopped when the eye feels well.

Graft failure — a cornea that clouds and stays clouded — also happens without rejection, through gradual loss of the pumping cells over years. Regrafting is possible and is a smaller decision after an endothelial graft than after a full-thickness one.

A transplant replaces cornea. It cannot improve vision limited by the retina, the optic nerve or long-standing amblyopia, and a clear graft in an eye with a damaged macula does not produce sight. Establishing what the rest of the eye can do before operating is part of the assessment, and there are eyes in which the honest answer is that a transplant is not worth what it costs the patient.

Dry eye

Dry eye is a disease of the tear film rather than a simple shortage of tears. The film has an oily outer layer that stops evaporation, a watery middle layer, and a mucin layer that lets it stick to the eye. If any of those fails, the film breaks up between blinks, the exposed surface becomes inflamed, the inflammation damages the glands and nerves, and the damaged glands produce a worse film. It is a self-sustaining cycle, which is why it rarely settles on its own.

The two kinds of dry eye

Evaporative dry eye is by far the commoner form. The meibomian glands in the lid margins produce the oil, and when their openings block and their secretion thickens, the tear film evaporates too fast even though the tear volume is entirely normal. Aqueous-deficient dry eye, in which the lacrimal gland does not produce enough fluid, is less common and is the type associated with autoimmune disease, particularly Sjögren syndrome. Most people have a mixture.

The distinction matters because the treatments differ. Pouring lubricant drops into an eye whose problem is blocked oil glands treats the symptom for twenty minutes and the cause not at all, and an assessment that does not look at the lid margins has not assessed the commonest cause.

Why a dry eye waters

The most confusing symptom is watering. A surface that dries out is an irritated surface, and irritation triggers the reflex tear gland to produce a flood of thin, poorly formulated tears that spill over the lid. Watering caused by dryness is common and is treated by treating the dryness. Watering caused by a blocked drainage system is a separate problem, described in Eyelid surgery that is not cosmetic, and distinguishing them is a matter of examination rather than guesswork.

What makes dry eye worse

• Screens. Blink rate falls sharply during concentrated visual tasks, and incomplete blinks fail to spread oil across the film.
• Age and hormonal change, particularly around and after the menopause.
• Medicines — antihistamines, several antidepressants, diuretics, some blood pressure drugs, hormone treatments and retinoids all reduce tear production or change tear composition.
• Preservatives. Long-term glaucoma drops containing preservative are a well-recognised cause of surface disease, which is why preservative-free formulations exist.
• Skin and lid disease — rosacea, blepharitis and Demodex infestation of the lash roots.
• Contact lenses, aircraft cabins, air conditioning, dry heat and wind.
• Previous laser vision correction, which cuts corneal nerves and weakens the feedback loop driving tear production.
• Anything that stops the lids closing fully, including thyroid eye disease and lid malposition.

How dry eye is assessed

A structured symptom questionnaire comes first, because symptoms and signs correlate poorly and a normal-looking eye can be very uncomfortable. Then: how long the tear film lasts before it breaks up, staining with dyes to show where surface cells have been damaged, tear osmolarity, tear volume, examination of the lid margins with expression of the oil glands to see what comes out, and imaging of the glands to see whether they have dropped out. Inflammatory markers and autoimmune testing are added when the picture suggests it.

Dry eye treatment, in the order it is actually used

Dry eye treatment is a ladder, and the rung matters. It begins with lubricants — preservative-free once drops are needed frequently, and thicker gels or ointments at night for surfaces that break down overnight — alongside warm compresses and lid hygiene for gland blockage, treatment of blepharitis, and attention to environment, screen habits and any contributing medicine, which is a conversation with the doctor who prescribed it rather than a decision to stop it.

When that is not enough, treatment moves to anti-inflammatory therapy, because inflammation perpetuates the cycle. Topical immunomodulators are used long term; short supervised courses of topical steroid break a flare and are not maintenance therapy, because of pressure rise and cataract with prolonged use. Punctal plugs close the drainage holes and keep what tears there are on the eye — useful in aqueous deficiency, less so when inflammation is untreated. In-clinic treatment of the oil glands, including thermal expression and intense pulsed light, targets the commonest mechanism directly. For severe surface disease there are autologous serum drops made from the patient’s own blood, and scleral lenses holding a reservoir of fluid against the cornea all day. Oral omega-3 supplementation is widely used and its trial evidence is mixed; saying so is more useful than selling it.

The honest limit of dry eye treatment

Dry eye is usually controlled rather than cured. Gland tissue that has already dropped out does not grow back, and the aim in established disease is a comfortable eye on a maintenance routine, not a surface that needs nothing. Treatment that works is treatment that continues; stopping generally means the symptoms return, and being told that at the start prevents the conclusion that the treatment failed.

Pterygium

A pterygium is a wing-shaped wedge of fibrous, blood-vessel-rich tissue that grows from the white of the eye across onto the cornea, almost always from the side nearest the nose. It is not a tumour and not a cataract, though it is regularly mistaken for both; it is an overgrowth of altered conjunctival tissue driven onto the cornea over years.

Pinguecula and pterygium: the difference that decides treatment

The distinction is whether the tissue has crossed onto the cornea. A pinguecula is the pterygium’s lesser relative: a raised yellowish patch on the white of the eye that stops at the edge of the cornea. Pingueculae are extremely common, can become inflamed, and generally need nothing beyond lubrication.

Sunlight, and who gets a pterygium

Ultraviolet exposure is the dominant risk. Prevalence rises steeply nearer the equator and among people who work outdoors — farmers, fishermen, builders, sailors — which is why it acquired the nickname surfer’s eye, and dust, wind and chronic surface dryness add to it. The nasal predominance is thought to reflect light entering from the side and being focused by the cornea onto the nasal limbus. Ultraviolet-blocking sunglasses that wrap around the face reduce exposure in a way flat lenses do not.

When pterygium removal is warranted

A pterygium that is not growing, not inflamed and not affecting vision is generally watched rather than removed, because surgery carries its own risk of a worse recurrence. The grounds for operating are specific.

• It is approaching or has reached the visual axis.
• It is distorting the cornea and inducing astigmatism, which shows up as vision that glasses no longer fully correct.
• It is repeatedly inflamed and lubricants no longer control the irritation.
• It is restricting eye movement or tethering the lid, which produces double vision in side gaze.
• Cataract or refractive surgery is planned, because a pterygium corrupts the corneal measurements that lens power is calculated from. Removing it first, and allowing the cornea to settle before measuring, is the correct sequence.
• Appearance, where the redness and the visible tissue matter enough to the person to accept the risk of recurrence.

Removing a pterygium, and recurrence stated honestly

The operation is done awake under local anaesthesia, usually as a day case. The head of the pterygium is peeled off the cornea and the body excised, and what happens next determines everything. Leaving the sclera bare has an unacceptably high recurrence rate and has been abandoned. The standard is to cover the defect with a free graft of the patient’s own conjunctiva, taken from under the upper lid and secured with fine sutures or fibrin glue; a graft including tissue from the limbus, where the corneal stem cells sit, is used in higher-risk cases.

Recurrence is the honest issue with pterygium surgery and it cannot be promised away. It is more likely in younger patients, in those whose original lesion was large and fleshy, and in those returning to the same intense sun and dust exposure. A recurrent pterygium tends to be more aggressive than the original, and revision surgery is harder. Adjunctive agents applied at surgery reduce recurrence and carry their own risk of poor scleral healing, so they are used selectively.

Recovery after pterygium surgery, and watching for regrowth

Afterwards the eye is red, gritty and uncomfortable for the first weeks. The graft site looks alarming while it settles and then becomes almost invisible. Anti-inflammatory drops are tapered over weeks, and the eye is watched for early regrowth, which is easier to control while it is still on the conjunctiva.

Children’s eyes: paediatric ophthalmology (pediatric ophthalmology)

A child’s visual system is not finished at birth. The eye can be structurally perfect and still never learn to see, because the pathway from the eye to the visual part of the brain develops only in response to being used. That fact governs children’s eye care: the priority is making sure both eyes deliver a usable image while the brain is still wiring itself.

Paediatric ophthalmology (pediatric ophthalmology)

Pediatric ophthalmology is the branch of the specialty that treats eye disease in children and manages the development of vision itself, together with strabismus in patients of any age. It is a separate subspecialty for practical reasons as much as clinical ones. Children cannot report symptoms reliably, cannot cooperate with adult tests, and need drops to relax their focusing before their glasses prescription can even be measured accurately. Orthoptists — clinicians trained specifically in measuring eye alignment and binocular function — do a large share of the work and are central rather than ancillary.

Lazy eye (amblyopia)

Lazy eye, or amblyopia, is reduced vision in an eye that is structurally normal, caused by that eye not having been used properly while the visual system was developing. The brain suppresses the poorer image to avoid confusion, and the suppressed pathway never fully forms. The eye looks entirely normal on examination; the deficit is in the connection, not the organ.

There are three routes to it. A turning eye sends a second, conflicting image, and the brain switches it off. A large difference in prescription between the eyes leaves one permanently blurred while the other is sharp, and the blurred one is switched off — the version most often missed, because the eyes look straight and the child behaves normally. And anything physically blocking the image in early life — a congenital cataract, a drooping lid over the pupil, a corneal opacity — quickly causes the most severe form, deprivation amblyopia.

Signs of a lazy eye in a child

The findings that prompt an examination in a young child are these:

• A visible eye turn.
• A persistent head tilt or face turn.
• Closing one eye in bright light.
• Holding objects very close.
• An absent or unequal red reflex in a photograph.
• Failing a vision screening check.
• Family history — strabismus, significant long-sightedness and amblyopia all run in families.

Amblyopia treatment, and the window that closes

Amblyopia treatment has a fixed order. First, correct the refractive error with glasses and wait — a substantial proportion of amblyopia improves on spectacles alone, over months, with nothing else done, and treating the eye further before that has happened is unnecessary. Any physical obstruction, such as a congenital cataract, is dealt with first and urgently, because deprivation in the first months of life causes damage fastest.

If a difference remains, the stronger eye is handicapped so the weaker one is forced to work: patching for a prescribed number of hours a day, or blurring drops that penalise the better eye, which some children tolerate better than an adhesive patch. This is supervised treatment with regular measurement, because the better eye can itself lose vision if occluded too heavily without review.

The window is real. The visual system is most plastic in the first years of life and responsiveness declines through childhood; conventional practice treats amblyopia most confidently under the age of about seven or eight. Meaningful improvement in older children and even adolescents is documented and treatment is not automatically refused on age, but the gains become smaller and slower, and vision lost to amblyopia in an adult is generally permanent. That is a fact about the condition, and it is the reason screening exists at the ages it does.

How a child’s eyes are examined

Vision is measured with pictures, matching cards or letters according to age, and in infants by observing which of two patterns the baby prefers. Alignment is measured with a cover test and prisms. Refraction is done under cycloplegia — drops that temporarily paralyse the focusing muscle — because children can accommodate strongly enough to hide a significant long-sighted prescription entirely. The drops sting briefly, blur near vision for hours and dilate the pupils, which is also how the retina and optic nerve are examined at the same visit. Where measurements cannot be obtained awake, such as pressure readings in a child with suspected glaucoma, an examination under general anaesthesia is arranged.

Short-sightedness in childhood

Myopia that begins in childhood tends to progress while the eye is still growing, and the final degree matters beyond the strength of the glasses, because high myopia carries lifelong risk of retinal detachment, myopic macular disease and glaucoma. Slowing progression is therefore treatment rather than convenience. What is used: low-concentration atropine drops, spectacle and soft contact lenses with a peripheral defocus profile, and orthokeratology lenses worn overnight. Time outdoors in daylight is consistently associated with slower progression, and near-work habits, screens included, are part of the same picture. None of these stops myopia; they slow it, and the child still needs correction.

Babies born early

Retinopathy of prematurity affects the developing retinal blood vessels of babies born very preterm or very small. It is screened on a schedule set by gestational age and birth weight, examined on the neonatal unit, and treated when it reaches defined stages, because the treatable window is narrow and the untreated disease can detach the retina. Children who had it need long-term eye follow-up even when the acute disease resolved, since squint, myopia and amblyopia are all more common afterwards.

Strabismus surgery

Strabismus surgery repositions the muscles that move the eye so that the two eyes point in the same direction. Six muscles are attached to the outside of each eye, and the operation weakens, strengthens or moves them to change the balance of pull. It is done on the surface of the eye, through the conjunctiva. The eye is not removed from the socket and is not detached from the optic nerve — the fear almost every patient arrives with, and the first thing worth correcting.

Strabismus surgery is not only cosmetic

Treating an eye turn as a purely cosmetic matter is the commonest misunderstanding about it, and it costs people treatment they need. Misalignment that develops in an adult produces double vision, and double vision is functionally disabling: it interferes with reading, with judging stairs and kerbs, with driving, and with any task requiring depth. Realigning the eyes restores single vision in the directions that matter and widens the field over which one image is seen instead of two.

There are other functional gains. Someone who tilts or turns the head to find the position where the eyes work together develops neck and postural problems from holding it, and surgery on the responsible muscle removes the reason for the tilt. In children, aligning the eyes protects binocular vision, which cannot be recovered later.

Appearance is a legitimate reason in its own right and does not need dressing up as something else. A visibly misaligned eye affects how people are addressed, interviewed and treated socially. Calling that vanity is both unkind and clinically wrong.

Strabismus surgery is not only for children

Adults are routinely told that nothing can be done because they were not operated on as children. That is out of date. Extraocular muscle surgery works mechanically at any age, and the muscles of a sixty-year-old respond to recession and resection as a six-year-old’s do. What differs is the sensory outcome, not the alignment: an adult whose brain never learned to fuse two images will usually not gain stereo vision, but the eyes can still be straightened and the head posture corrected.

Adult strabismus also arises fresh, and those causes are their own reason to operate:

• A cranial nerve palsy from microvascular disease, diabetes, trauma or a lesion pressing on the nerve.
• Thyroid eye disease, in which the muscles become fibrotic and restrict movement.
• An orbital floor fracture trapping a muscle.
• Muscle disease and myasthenia.
• Drift of a childhood squint stable for decades.
• Scarring after retinal or previous strabismus surgery.

Each is investigated for its cause before anything is operated on, because operating on the eye of someone whose real problem is neurological treats the wrong thing.

The measurements that come before strabismus surgery

The surgical plan is arithmetic performed on measurements, and the measurements are the operation. An orthoptic assessment records the angle of deviation in each of nine directions of gaze, at distance and at near, with and without glasses, repeated on separate occasions where the angle varies. It documents how far each eye moves, tests whether the two eyes can work together at all, and measures vision in each. In restrictive disease a forced duction test under anaesthesia establishes whether the eye is physically tethered or simply weak — a distinction that changes the whole plan.

Stability is the precondition. A cranial nerve palsy is observed for a period of months, conventionally at least six, because spontaneous recovery is common and operating on a moving target produces a poor result. Thyroid eye disease is not operated on until the inflammatory phase has settled and the measurements have stopped changing. Prisms, occlusion of one eye and botulinum toxin injected into a muscle manage double vision meanwhile — and the toxin is sometimes diagnostic too, showing what the eye will look like and whether the new alignment will be tolerated.

What strabismus surgery involves

An incision is made in the conjunctiva, the muscle is isolated on a hook, and it is either detached and reattached further back to weaken it, or shortened to strengthen it. Where a muscle no longer works at all, a working muscle may be transposed to take over part of its job. Usually one to four muscles are operated on across one or both eyes, and it is normal for the eye that looks straight to be operated on as well as the one that turns, because the correction is shared between them.

Children have this under general anaesthesia (general anesthesia). Adults may have general or local anesthesia depending on what is being done and on preference. It is generally a day case, and the conjunctival incision is closed with dissolving sutures — there is no cut in the skin.

Adjustable sutures

In cooperative adults, the reattached muscle can be tied with a temporary knot left accessible. Some hours after surgery, once the patient is awake and sitting up, the alignment is measured again and the suture tightened or loosened under anaesthetic drops before being tied off. It converts a single intraoperative estimate into a measured correction and reduces the chance of a second operation, and it requires the patient present and cooperative on the day — a real consideration when travel is involved.

Recovery after strabismus surgery, and the limits

The eye is red — often dramatically so — for weeks, and the redness fades long after the eye is comfortable. It feels gritty rather than deeply painful, movement aches for the first days, and drops are used while the surface heals. Double vision is common at first as the brain adapts to a new alignment, and usually settles. Most people return to ordinary activity quickly; swimming and dusty environments wait until the surface has healed.

The limits deserve stating plainly. Under-correction and over-correction are the commonest outcomes short of success, and a proportion of patients need a further procedure — sometimes years later, because muscle balance drifts over a lifetime. Persistent double vision in a new position of gaze is the risk taken most seriously when operating on an adult with long-standing suppression, which is why a preoperative prism trial is used to test for it. A slipped or lost muscle is rare and serious. Perforation of the eye wall by a needle, infection, and inflammation of the front of the eye when several muscles are operated on at once are all described. Conjunctival scarring makes future surgery harder, which is a reason not to operate more times than necessary. And surgery corrects alignment; it does not improve the vision of an amblyopic eye.

Eyelid surgery that is not cosmetic: ptosis surgery, entropion and tear drainage

The eyelid is a functional structure. It spreads the tear film across the cornea with every blink, pumps tears into the drainage system, holds the lashes off the surface, and closes to protect it. When any of those jobs fails the consequence lands on the cornea, and the surgery correcting it is done to protect sight rather than to change appearance. Eyelid surgery performed to change how the lids look — blepharoplasty for hooding, bags and ageing — is the province of Plastic Surgery, and that unit owns it.

Ptosis: a lid that blocks the visual field

Ptosis is a drooping upper eyelid. It matters when the lid margin cuts into the visual field, experienced as a shrinking of the top of what is seen, brow-ache from constantly lifting the brow to compensate, and a growing tendency to tilt the head back to see under the lid.

The cause determines the operation, so it is established first. Age-related ptosis is the commonest: the tendon connecting the lifting muscle to the lid stretches or slips, the lid drops while the muscle still works well, and the crease sits unusually high. It is more frequent after previous eye surgery and in long-term rigid contact lens wearers. Congenital ptosis is a developmental problem of the lifting muscle itself, with a poorly formed crease and limited lid movement; in a child it is judged by whether it obstructs the visual axis, because a lid covering the pupil causes deprivation amblyopia, so the timing follows visual development rather than appearance. Neurological causes include third nerve palsy, Horner syndrome and myasthenia, in which the droop varies through the day and worsens with fatigue. Muscle disease and mechanical causes make up the rest.

Assessment measures the distance from the pupil light reflex to the lid margin, how far the lid travels between full down-gaze and full up-gaze, the position of the skin crease, and the state of the tear film. A visual field test with the lid taped up and again untaped documents the functional loss objectively. Because a droop on one side can mask a droop on the other, the second lid is reassessed once the first is corrected. A third nerve palsy with an enlarged pupil is investigated urgently for its cause before lid surgery arises as a question at all.

Ptosis surgery, and how the operation is chosen

Ptosis surgery is selected on how much the lifting muscle can still do. Where the muscle works well, the tendon is reattached or shortened through an incision in the natural skin crease, often with the patient awake and sitting up so the height can be checked during the operation. Where the droop is small and responds to a test drop stimulating the accessory lifting muscle, a shorter operation from inside the lid avoids a skin incision altogether. Where the muscle barely functions — most congenital cases — the lid is suspended from the brow with a sling of the patient’s own fascia or synthetic material, and is thereafter lifted by the forehead muscles.

The risks of ptosis surgery, and revision

The risks of ptosis surgery are specific. Asymmetry between the two lids is the commonest problem and the usual reason for revision; matching height exactly is genuinely difficult and a second adjustment is not a rarity. Over-correction leaves the lid unable to close fully, which dries and can ulcerate the cornea, and existing dry eye reliably worsens after the lid is raised because a wider opening evaporates more. Contour irregularity, an asymmetric crease and altered lash position all occur, and a sling can loosen and need redoing. Raising a lid that had been covering one eye can also uncover double vision the droop was concealing, which is why a squint assessment forms part of the work-up in neurological ptosis.

Entropion and ectropion

Entropion is a lid that rolls inward, so that the lashes and the keratinised lid margin sweep across the cornea with every blink. It is nearly always the lower lid and nearly always age-related. The consequence is not discomfort alone: constant abrasion causes surface breakdown, and continued rubbing leads to ulceration and scarring. Scarring of the inner lid surface — chemical injury, severe inflammatory disease, trachoma, years of topical medication — produces a harder version that pulls the lid inward from behind. Lubrication, taping and botulinum toxin hold the position while surgery is arranged; the repair tightens the lid and reattaches the retractors, and the scarring type needs the internal plate rotated or grafted.

Ectropion is the opposite: the lid falls away from the eye, through age-related laxity, through facial nerve weakness that stops the lid closing at all, or through a shortage of skin from sun damage, burns or previous cosmetic lower-lid surgery. The exposed inner surface dries and thickens, the cornea is exposed, and because the drainage opening no longer touches the eye, the eye waters constantly. Repair follows the cause: tightening for laxity, a stitch that rotates the inner corner, or a skin graft where tissue is genuinely missing.

Watering eyes and blocked tear ducts

A watering eye has one of two mechanisms: too many tears being made, or too few getting away. Excess production is usually reflex, driven by a dry or irritated surface — the mechanism set out under dry eye — by lashes rubbing, or by entropion, which is why the assessment starts with the surface and the lid position rather than with the drain. Poor drainage means an obstruction along the route from the openings at the inner corner of the lids, through the canaliculi, into the tear sac and down into the nose; it also results from a lax lid whose pump no longer works, or from a drainage opening that has narrowed or turned away from the eye.

The examination distinguishes them directly: a dye placed in the eye is watched to see whether it clears, the system is syringed to establish whether fluid reaches the nose and where it stops, and nasal endoscopy inspects the far end. A tender swelling over the tear sac indicates infection of an obstructed sac, which is treated before any reconstruction.

Treatment follows the level of the blockage. A narrowed opening is widened. An obstruction downstream of the tear sac is bypassed by dacryocystorhinostomy, which creates a new opening from the sac into the nose, either through a small incision beside the nose or endoscopically through the nostril with no external scar. Obstruction in the canaliculi themselves is hardest to fix and gives the least reliable results, and saying so beforehand is more useful than optimism. In babies the duct is often simply not yet open at birth; most clear spontaneously during the first year, and probing is reserved for those that do not.

The team

Ophthalmology at Acıbadem International is organised by subspecialty rather than as a single pool of eye doctors. Which clinician sees a patient depends on which part of the eye is involved, and for several conditions that choice changes the answer more than anything else.

The subspecialties inside an eye department

Cataract and refractive surgeons handle lens replacement and laser vision correction. Cornea and ocular surface specialists cover keratoconus, cross-linking, transplantation, infections and dry eye. Glaucoma specialists manage pressure, medical treatment, laser and drainage surgery. Medical retina looks after macular degeneration, diabetic eye disease and the injection programmes, while vitreoretinal surgeons operate inside the eye for detachment, macular holes and vitreous haemorrhage. Paediatric ophthalmology and strabismus covers children and eye alignment at every age. Oculoplastic surgeons do the functional lid, orbit and tear drainage work, neuro-ophthalmology the optic nerve and visual pathway, and uveitis specialists intraocular inflammation.

Who else is in the room

Most of what an eye department produces is measurement, and much of it is not produced by doctors. Optometrists refract and manage contact lenses, including the specialist rigid and scleral fitting keratoconus depends on. Orthoptists measure alignment and binocular function and run amblyopia treatment. Technicians and photographers perform the scans, fields, biometry and angiography. Around them sit the theatre teams, anaesthetists, and coordination with the eye bank for transplant tissue. Low vision services exist for patients whose sight cannot be restored, and referral to them is part of care rather than an admission of failure.

Where subspecialty focus changes the answer

A keratoconic cornea assessed without tomography and without a specialist lens fitter is likely to be told nothing more can be done when a scleral lens would have transformed it. A macular hole belongs with a vitreoretinal surgeon. A squint in a child needs an orthoptic department, not a clinician with an occasional interest. Complex, low-volume procedures — endothelial keratoplasty, adjustable-suture strabismus surgery, lacrimal reconstruction — depend on technical repetition more than most eye surgery does, which is why they belong with a surgeon who performs them regularly rather than occasionally.

Where the eye department hands over

Thyroid eye disease is shared, with the endocrine management on one side and the orbit, lids and squint on the other. Rheumatology co-manages uveitis and Sjögren syndrome, endoscopic tear-duct surgery is often performed jointly with ENT, and tumours of the eye and orbit involve Radiology, Medical Oncology and Radiation Oncology. Where aesthetic eyelid surgery, diabetes control or the management of multiple sclerosis is the real question, it sits with another unit, as set out under what this unit covers. A named responsible ophthalmologist and a written plan saying who is doing what are part of the record in every one of those arrangements.

Coming from abroad

Eye care travels better than most specialties, because so much ophthalmic surgery is day surgery on an awake patient. What it does not tolerate is poor sequencing. Several treatments are programmes rather than events, several assessments cannot be done until something else has been done first, and one restriction after retinal surgery is absolute.

What can usually be finished in one visit

A complete examination is a sequence of stations rather than a single consultation and takes most of a day. Cataract surgery on both eyes is staged with an interval between them, so how it maps onto a trip depends on the interval the surgeon sets for that pair of eyes; the same applies to YAG laser for a clouded capsule, cross-linking, pterygium removal, functional lid surgery and strabismus surgery. Laser vision correction is assessed and treated within one visit but not on the same day, because contact lenses must be out long enough for the cornea to return to its own shape before measurements are taken — the contact lens holiday described under laser vision correction — with the interval set before travel rather than on arrival.

What should not be started without follow-up in place

Some eye treatments are commitments. Injections for wet macular degeneration and for diabetic macular oedema are a repeating programme whose effect is not durable — the details are in Injections into the eye — and starting a course without agreeing who continues it and monitors the response is not responsible care. Glaucoma is lifelong monitoring, and its value is in the sequence of fields and scans over years rather than any single visit. A corneal transplant needs suture management, a slow steroid taper and indefinite surveillance for rejection. Amblyopia treatment is months of supervised patching with regular remeasurement. Cross-linking needs a repeat scan to confirm the cornea has stabilised.

None of this argues against being treated away from home. It argues for agreeing, before travel, who does the follow-up, and for leaving with documentation good enough to work from. Where no such arrangement can be made, the honest answer is that the treatment should not be started, and that answer is part of the assessment.

The order things have to happen in

Several eye procedures depend on measurements of the cornea, and anything that distorts the cornea distorts the calculation. An untreated dry surface produces unreliable keratometry, so ocular surface disease is treated before the biometry for a lens implant or the topography for laser correction is trusted. A pterygium touching the cornea is removed and the cornea allowed to settle first. Contact lenses are out for their full washout first. A cloudy lens changes a refractive answer, so cataract surgery comes before a refractive assessment is meaningful. A trip built without that order produces measurements that have to be repeated and decisions that have to be undone.

Records worth bringing

• Old glasses prescriptions with their dates — the sequence, not just the current one, because progression is the diagnosis in keratoconus and in childhood myopia.
• Previous corneal topography or tomography, with the device named on the printout, and optical coherence tomography as the original data on a disc or drive rather than a photograph of a screen.
• Every previous visual field printout, not only the most recent; a single field cannot show progression.
• Operative notes from any previous eye surgery, including the model and power of any lens implanted, and the record of any injections given — which drug, which eye, which dates.
• Every eye drop listed by active ingredient rather than brand, with how long each has been used.
• All systemic medicines, blood thinners included, plus allergies and any previous reaction to anaesthesia.
• For diabetic patients, recent glycaemic control results and the date of the last retinal screening.
• Current glasses, and current contact lenses in their case with the boxes showing the parameters.

Why some eye tests are repeated here

Being asked to repeat a recent test is a fair thing to question, so here are the actual reasons. Corneal tomography and retinal scans are device-specific: normative databases and layer segmentation differ, and a thickness in microns from one machine is not comparable with another’s. Visual field progression analysis requires the same instrument and test strategy throughout the series. Biometry must be measured on the device whose lens constants have been optimised here, because the implanted power is calculated from them. Eye pressure varies through the day, and a scan from a year ago describes a retina as it was then. What should not happen is a repeat with no explanation of which reason applies.

Flights, and the one absolute restriction

Most eye surgery places no restriction on flying beyond ordinary comfort — a recently operated eye is dry and light-sensitive in a cabin, which is a matter of lubricants rather than safety. There is one exception and it is absolute. When a gas bubble has been left inside the eye after retinal surgery, the gas expands as cabin pressure falls and the pressure inside the eye can rise to a level that damages sight permanently. Flying is prohibited until the gas has gone, confirmed by examination rather than by a date on a calendar; Vitrectomy covers the bubble itself. The practical consequence is that a return flight after retinal surgery cannot be fixed in advance, and a changeable ticket is the realistic response.

Practical notes

Most of what goes wrong around an eye appointment is logistical rather than medical: nobody expected the dilating drops, the wrong glasses were brought, a new pair was ordered too soon.

Dilating drops, and the hours afterwards

Any proper examination of the retina and optic nerve requires the pupils to be dilated, and the drops are given routinely rather than exceptionally. They sting briefly and take a while to work, so the appointment has a waiting gap built into it. Afterwards the pupils stay large for several hours and sometimes into the next day: near vision is blurred, bright light is genuinely painful, and driving is not possible during that period. Clinics assume someone else is doing the driving and that no important reading is planned for the rest of the day. Dark glasses for the journey home are the most useful thing to have in a bag. In children the drops are stronger and last longer.

How long an eye appointment actually takes

It is a sequence of stations rather than one consultation, and it takes hours rather than minutes: vision measured with and without correction, the prescription machine-measured then refined by hand, the pressure taken, scans of the cornea and retina, a visual field test that demands sustained concentration and is tiring, the slit-lamp examination, the drops, and the retinal examination after the wait. The consultation that draws it together comes at the end, which is why the appointment cannot be compressed into a short slot.

New glasses, and why the timing matters

The prescription is unstable after any operation that changes the eye’s optics, and buying glasses before it settles wastes the money. After cataract or refractive lens surgery the refraction settles over some weeks, and a final prescription is issued once it is stable and any needed laser capsulotomy has been done; after laser vision correction the eye changes for a similar period. After a full-thickness corneal transplant the astigmatism keeps moving for as long as the sutures are being managed, and interim spectacles are a stopgap. Contact lens fitting waits until the surface has healed completely.

Being awake for eye surgery

Nearly all adult eye surgery is done with the patient awake, under anaesthetic drops or a local anaesthetic injection around the eye. Sedation is common, but general anesthesia is the exception in adults, reserved for long operations, for patients who cannot lie still, and for children. What being awake is like is worth describing plainly, because the imagined version is worse than the real one: the eye is numb, a drape covers the face with oxygen flowing under it, a clip holds the lids so there is no need to hold the eye open, and what is seen is bright light and moving colour, not instruments and not the operation. There is pressure, and sometimes water running across the face. Talking to the team is normal. For adjustable-suture strabismus surgery and some ptosis operations, being awake is useful rather than merely tolerated.

How eye results are written down

Eye reports are dense with abbreviations and units that differ between countries, and a report the next clinician cannot read has lost most of its value. Visual acuity is recorded in several notations — a six-metre fraction, a twenty-foot fraction, a decimal logarithmic score — and the same vision looks like a different number in each. Pressure is in millimetres of mercury, with central corneal thickness alongside it because a thick or thin cornea shifts the reading. Scan values name the device, since the numbers are not interchangeable between machines, and drops are listed by active ingredient because brand names change at every border. A report that travels is issued in a language the receiving department reads, with raw scan data supplied as digital files rather than printed images, so the eye department nearest home can re-read the actual study rather than a picture of it.